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Abstract 
Juei-Chuan Connie Kang-Sickel 
Keratin Adducts as Biomarkers for Dermal Exposure to Jet Fuel JP-8 in the U.S. Air Force 
Fuel Cell Maintenance Personnel 
(Under the Direction of Dr. Leena A. Nylander-French) 
 
Jet propulsion fuel, JP-8, is the fuel of choice for all military operations in the United States 
and the North Atlantic Treaty Organization.  Dermal exposure to jet fuel JP-8, along with 
inhalation exposure, has been observed to contribute significantly to the total body burden in 
the U.S. Air Force fuel-cell maintenance personnel.  However, current dermal exposure 
assessment methodologies are either qualitative or reflect only acute exposure scenarios 
occurring during the day of sampling.  A quantitative method that measures the long-term, 
cumulative dermal exposure is needed.  In order to improve the current dermal exposure 
assessment methodologies, I developed four polyclonal antibodies to four hypothetical 
synthetic keratin adduct epitopes and validated enzyme-linked immunosorbent assays to 
quantitatively detect naphthyl-keratin adducts (NKA) predicted to be formed in the stratum 
corneum upon exposure to naphthalene-containing JP-8.  I also demonstrated the existence of 
xenobiotic metabolism and dose-related induction in mRNA transcripts for various 
xenobiotic-metabolizing enzymes in the three-dimensional (3D) reconstructed human skin 
exposed to naphthalene.  Most importantly, I demonstrated the dose-related NKA formation 
consistent with the hypothetical synthetic epitopes both in vitro in the 3D reconstructed 
human skin using in situ immuofluorescence and in vivo in skin samples collected from the 
fuel-cell maintenance workers exposed to naphthalene-containing JP-8.  The measured total 
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NKA (TNKA) levels were affected by exposure time, dermal naphthalene level, and 
worker’s age.  A significant association was observed between TNKA and urine naphthalene 
levels, which indicates a contribution of dermal metabolism to systemic exposure.  In 
addition to the TNKA level, post-exposure breath naphthalene level, as well as the presence 
of GSTT1-plus (++/+-) and CYP2E1*6 wild-type (DD at the DraI restriction site of intron 6) 
significantly influenced urine naphthalene levels.  This research is the first to confirm that 
naphthalene is readily metabolized and that reactive naphthalene metabolites form keratin 
adducts in the human skin, both in vitro and in vivo.  Further, this research demonstrates the 
potential utility of using NKAs as biomarkers of cumulative dermal exposure to JP-8.  These 
keratin adducts can also be utilized as biomarkers of exposure in occupational and 
environmental exposure settings where naphthalene can be used as a marker of exposure to 
complex mixtures (e.g., PAH exposure). 
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Chapter 1 
Background and Significance 
1.1 Jet Fuel and Naphthalene 
Jet propulsion fuels (kerosene-based fuel mixtures) are standard fuels for commercial 
aviation as well as for military aircrafts and vehicles.  These fuels have been recognized as a 
major source of chemical exposure for military personnel of the North Atlantic Treaty 
Organization (NATO) allies (ATSDR, 1998; Zeiger and Smith, 1998; Carlton and Smith, 
2000; NRC, 2003).  Jet propulsion fuel type 8 (JP-8) is the battlefield fuel of choice for all 
military operations in the United States and was chosen to replace its predecessor JP-4 in 
1972 by NATO.  It is used not only in aircrafts but also in military vehicles, and as a 
degreaser and heat source.  It is estimated that 5 billion gallons of JP-8 is used by the U.S. 
military and NATO each year (NRC, 2003). 
Dermal exposure to jet fuel, along with inhalation exposure, was observed to 
contribute significantly to the total body burden in the US Air Force (USAF) fuel-cell 
maintenance workers (Chao et al., 2005; Kim et al., 2007).  Skin contact with a jet fuel can 
lead to exposure to hundreds of different hydrocarbons and other compounds, which may 
cause a number of local and systemic health effects.  Following exposure, absorption of jet 
fuel and its components into the different layers of the skin may cause degradation of skin 
barrier properties, physical irritation, dermatitis, allergic contact sensitization, and 
carcinogenic effects.  Further, the compounds may be absorbed into the vascular system and,
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thus, increase risk for systemic toxic effects.  Adverse human health effects associated with 
jet fuel exposure include nausea, dizziness, headache, fatigue, and respiratory distress (Knave 
et al., 1976; Smith et al., 1997; Zeiger and Smith, 1998), neurocongnitive changes (Tu et al., 
2004), psychiatric disorders (Knave et al., 1976; Mindus et al., 1978; Struwe et al., 1983), 
and posture balance problems (Smith et al., 1997).  Adverse effects on reproductive and 
immune systems have also been reported (Reutman et al., 2002; Rhodes et al., 2003).  
Immune suppression, systemic toxicity, and skin cancers have been observed in animal 
studies as the results of JP-8 exposure (Ullrich, 1999; Ullrich and Lyons, 2000; Harris et al., 
2001; McDougal and Rogers, 2004).  Epidemiology studies also suggested association 
between jet fuel exposure and human cancers (Siemiatycki et al., 1987; Smith et al., 1997; 
Parent et al., 2000).  Despite a number of studies conducted on jet fuel exposed populations, 
knowledge of jet fuel exposure, uptake, metabolism, and its potential health effects on 
humans is limited. 
Naphthalene, a major constituent of JP-8, and the simplest form of polycyclic 
aromatic hydrocarbon (PAH), is associated with hemolytic anemia, cataract, and is a possible 
human carcinogen (NTP, 2000).  Naphthalene is metabolized into 1-naphthol and 2-naphthol 
in the human body (Tingle et al., 1993; Wilson et al., 1996; NTP, 2000).  The potential 
contribution of JP-8 dermal exposure to increase biomarker levels (i.e., urinary 1- and 2-
naphthol) was implied based on surrogate factors used as indicators of dermal exposure (e.g., 
skin irritation, work inside the fuel cell, cleaning fuel puddles) (Egeghy et al., 2003; Serdar et 
al., 2004). 
1.2. JP-8 Exposure Assessment 
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The assessment of JP-8 exposure have been conducted using tape-strip sampling of skin, 
passive sampling of end-exhaled breath, breathing-zone air, and biological monitoring of 
urine for either metabolites or parent compounds (Egeghy et al 2003; Chao et al 2005 and 
2006, Serdar et al 2003 and 2004).  Naphthalene, a major constituent of JP-8, is metabolized 
into 1-napthol (1-NAP) and 2-naphthol (2-NAP) in the human body, and they have been 
indicated as useful surrogate biomarkers for jet fuel exposure (Serdar et al., 2003).  Urinary 
2-NAP has been used as a PAH exposure biomarker and has been validated as a stable and 
robust biomarker under variable storage conditions (Kang et al., 2002; Lee and Kang, 2008).  
It has been suggested that urinary naphthalene may also be used as a biomarker for PAH 
exposure (Sobus et al., 2009a; Sobus et al., 2009b; Campo et al., 2010).  Many of these 
studies, however, considered only inhalation exposure to ambient PAHs in the general 
population, without the consideration of potential contribution of dermal exposure route 
(Yang et al., 1999; Kim et al., 2001), or a qualitative dermal exposure measure was used 
instead of a quantitative method (Serdar et al., 2004).  Thus, it is very likely that dermal 
contribution of JP-8 exposure using urinary naphthol levels have been underestimated in 
these studies.  Understanding the contribution of dermal exposure to the systemic dose is 
especially relevant for fuel-tank maintenance workers, who enter aircraft tanks to perform 
maintenance duties and often wear only cotton overalls due to concerns over possible static-
induced fire and explosion hazard. 
Accurate estimation of the contribution of dermal exposure to the systemic dose is 
required in order to complement and improve current exposure assessment models for long-
term health effects of jet fuel exposure, a facet that is missing from current epidemiological 
research.  Quantitation of the individual dermal dose and determination of a mechanism of 
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action hinges upon identification of appropriate biomarkers of exposure that can discriminate 
between acute and chronic exposure, and also on development of quantitative analytical 
procedures.  The only method for quantitation of dermal dose due to jet fuel exposure 
reported to date (Chao et al., 2005; Chao et al., 2006) detects the unchanged naphthalene 
(parent compound) on the surface of the skin, which can be attributed to recent exposure 
only.  Adducts bound to keratin would be the appropriate biomarkers for cumulative 
exposure, as the bioactivation required to generate these adducts from naphthalene occurs 
only in the suprabasal layer of the epidermis, where keratin is synthesized de novo.  
Approximately 28 days are required for differentiation and maturation of suprabasal 
keratinocytes (Junqueira and Carneiro, 2005; Furukawa et al., 2008) to migrate from the 
basal layer to form the stratum corneum.  Thus, periodic non-invasive sampling by tape 
stripping can be used to determine prior and cumulative chronic exposure and to provide 
some measure of individual variation in metabolic capacity. 
1.3. Skin Physiology and Metabolic Enzymes 
There are many layers of cells in the epidermis, which possess different properties and 
characteristics (Figure 1.1).  The cells in the basal layer proliferate and start differentiating 
and migrating to the surface.  The differentiating basal keratinocytes express various 
differentiation markers, including large amounts of keratin 1 (K1) and keratin 10 (K10) 
proteins (Schweizer and Winter, 1983; Self et al., 1986).  The cells increase in size once they 
enter the spinous layer and migrate further to the granular layer, in which all the cytoplasmic 
organelles are eliminated, and the keratins become the principal proteins in the cytoplasm 
(Fuchs and Green, 1980).  Research has shown that the epidermis contains xenobiotic-
metabolizing enzymes (Janmohamed et al., 2001; Saeki et al., 2002; Yengi et al., 2003; Du et 
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al., 2004) and the keratinocytes in the epidermis can metabolize naphthalene and other PAHs, 
which have been absorbed into viable epidermis, to electrophilic metabolites that may adduct 
nucleophilic sites on the keratin proteins in the suprabasal layer of the viable epidermis 
(Watt, 1988a; Watt, 1988b).  Theses metabolites are likely to adduct to the nucleophilic 
cysteine residues on the head region of the N-terminal of K1 and K10 proteins, which are the 
preferred adduction sites on proteins, albumin and hemoglobin (Rappaport et al., 1996; 
Yeowell-O'Connell et al., 1996; Rombach and Hanzlik, 1999).  The adducted keratinocytes 
may then be available for exposure monitoring after keratinocytes differentiate, mature, and 
migrate to the stratum corneum. 
 
Figure 1.1. Schematic diagram of skin keratinocyte maturation and differentiation process.  
http://www.genome.gov/Pages/Research/DIR/GenomicsinAction/ga_segre_skin2.
htm 
Until recently, skin has been considered as a passive structure barrier between the 
body and environment.  However, research has shown that human skin keratinocytes express 
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myriads of transport and metabolic enzymes providing active uptake and biotransformation 
of many xenobiotics, including drugs, solvents, and carcinogens (Baron and Merk, 2001; 
Janmohamed et al., 2001; Saeki et al., 2002).  There are two major phases in xenobiotic 
metabolism: phase I metabolism incorporates a polar reactive group into an inert molecule 
through oxidation, reduction, or hydrolysis.  These molecules are then further conjugated and 
processed by the phase II enzymes in order to make the compound more hydrophilic to be 
excreted out of the body.  Among these metabolic enzymes, cytochrome P450s play a major 
role in phase I metabolism of endogenous and xenobiotic compounds in humans.  PAHs, 
such as naphthalene, are known to be metabolized by cytochrome P450 isomers, such as 
CYP2E1, CYP1A1, and CYP1A2 (Farin et al., 1995; Lee et al., 2001; Nan et al., 2001; Kim 
et al., 2004; Castorena-Torres et al., 2005), and further processed by Phase II enzymes, such 
as glutathione-S-transferase mu (GSTM1) and theta (GSTT1) (Gabbani et al., 1999; 
Godschalk et al., 2001; Lee et al., 2001; Nan et al., 2001).  Inter-individual differences in 
response to chemical exposure are often the results of genetic polymorphisms in these 
xenobiotic-metabolizing enzymes.  Since PAH metabolism is a complex process with high 
individual variation, it has been suggested that markers related to PAH exposure (dermal and 
inhalation) and metabolic capacity (genotypes) are helpful in exposure and risk assessment 
(Hemminki et al., 1997).  For instance, GSTM1 is involved in detoxification of PAHs but 
approximately 50% of the Caucasian population has a homozygous deletion of this gene.  It 
is estimated that 20% of Caucasians and more than 60% of Asian populations have partial 
deletions in GSTT1 (Eaton, 2000).  Many studies have shown the association between 
genetic polymorphisms in cytochrome P450s, GSTs, and urinary concentrations of PAH 
metabolites (Merlo et al., 1998; Ovrebo et al., 1998; Yang et al., 1999). 
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Urinary naphthols have been suggested as reliable biomarkers of exposure to JP-8 
(Serdar et al., 2003; Serdar et al., 2004), and dermal route has been shown to contribute 
significantly to the total body burden in the fuel-cell maintenance personnel (Chao et al., 
2006).  The induction of CYP2E1 is known to increase the formation of naphthols from 
naphthalene, and the polymorphisms in this gene are associated with urinary 2-NAP levels in 
Korean coke oven workers, who were exposed to PAHs (Wilson et al., 1996; Nan et al., 
2001).  Studies also showed the GSTM homozygous null individuals have higher urinary 1- 
or 2-NAP levels, or both, than the non-null individuals (Yang et al., 1999; Nan et al., 2001).  
However, there is no significant association between GSTT1 and the metabolism of 
naphthalene or pyrene (Lee et al., 2001). 
NAD(P)H:quinone oxidoreductase (NQO1) is an important xenobiotic-metabolizing 
enzyme that can be induced by variety of PAHs, including naphthalene (Elovaara et al., 
2007).  Once naphthalene is biotransformed by cytochrome P450s into reactive 
naphthoquinones, NQO1 is induced to protect cells against oxidative damages by catalyzing 
two-electron reduction of the naphthoquinones (Joseph and Jaiswal, 1994; Hung et al., 2004).  
NQO1 is expressed in kidney, liver and skin tissues and its anticarcinogenic properties have 
been attributed to its function in antioxidant defense and stabilization of the tumor suppressor 
protein p53 (Asher et al., 2004).  The C>T single nucleotide polymorphism (SNP) at 690 
base pair is found to cause proline-to-serine replacement at codon 187, which has been 
associated with lower enzyme activity when compared to wild-type (Ross et al., 1996; Siegel 
et al., 1999). 
1.4. Enzyme-linked Immunosorbent Assay 
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Studies showed that naphthalene and benzene are metabolized by cytochrome P450 
(CYP2E1) into eletrophilic arene oxides, which may react with nucleophilic cysteine to form 
protein adducts on the head region of K1 and K10, the most abundant proteins in the stratum 
corneum.  Although little literature is available on immunochemical assays for detecting 
protein adducts, haptens containing partial sequences of the adducted protein were 
successfully utilized to raised antibodies against keratin adducts of sulfur mustard exposure 
(van der Schans et al., 2002), and acetaldehyde adduct of murine hair after alcohol exposure 
(Watson et al., 1998). 
Enzyme-linked immunosorbent assay (ELISA) is a cost-efficient method that can be 
utilized to detect adducts in protein or DNA as biomarkers of exposure.  First, the unknown 
concentrations of samples and serial dilutions of standard antigens are affixed to the surface 
of micro-well plates (Figure 1.2).  The primary antibody, which binds specifically to the 
target protein is then added into the plate.  A second antibody with attached enzymes, which 
binds to the primary antibody is then added.  At the last step, a substrate is added and is 
converted by the enzyme to form a colorimetric signal.  The signal intensity is correlated 
with the amount of binding occurring between the primary antibody and its target protein.  
Therefore, the concentration of each unknown sample can be extrapolated using a standard 
curve.  Using the ELISA technique coupled with the tape-strip method provides a quick, 
simple, and non-invasive detection method for naphthalene-containing jet fuel or other PAH 
mixtures containing naphthalene.  Furthermore, ELISA technique has been widely utilized in 
both research and clinical settings for detection of other environmental pollutants and 
carcinogens (Weston et al., 1988). 
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Figure 1.2. Schematic diagram of indirect enzyme-linked immunosorbent assay (ELISA). 
 http://entomology.tfrec.wsu.edu/VPJ_Lab/images/indirect_elisa.jpg. 
1.5. Study Objectives and Specific Aims 
The overall goal of my research was to improve the current exposure assessment 
methodologies by developing specific biomarkers of dermal exposure (i.e., naphthyl-keratin 
adducts) to quantitate jet fuel exposure in fuel-cell maintenance workers.  In addition, I 
sought to investigate factors that influence these dermal biomarker levels as well as the 
relationship between these adducts and other jet fuel exposure biomarker levels, such as 
dermal, breath, and breathing-zone naphthalene and urinary naphthalene and naphthol levels.  
I proposed to test the following hypotheses: (1) various xenobiotic-metabolizing enzymes are 
induced and naphthyl-keratin adducts (NKAs) are formed upon exposure to naphthalene-
containing jet fuel and can be detected by ELISA utilizing affinity-purified polyclonal 
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antibodies; (2) the NKA levels are quantitative biomarkers of the cumulative dermal 
exposure to jet fuel (JP-8); and (3) the NKA levels measured in exposed workers are 
influenced by work environment (e.g., job tasks, use of personal protective equipment) and 
personal factors (e.g., age, individual metabolic genotype).  To test these hypotheses, I 
proposed the following specific aims: 
1. Develop ELISA for NKA quantitation utilizing polyclonal antibodies specific to the 
NKAs formed in the viable epidermis in workers exposed to the naphthalene-containing 
jet fuel. 
2. Investigate NKA formation and xenobiotic-metabolizing enzyme induction in vitro 
utilizing three-dimensional reconstructed human full-thickness epidermis and in vivo 
using tape-stripped skin samples obtained from workers exposed to naphthalene-
containing jet fuel. 
3. Determine the personal and work environment factors that modify the relationship 
between the measured NKA levels and exposure to jet fuel in fuel-cell maintenance 
workers.
 
 
Chapter 2 
2. Paper I. S-Arycysteine-Keratin Adducts As Biomarkers of Human Dermal Exposure 
to Aromatic Hydrocarbons 
Juei-chuan C. Kang-Sickel, Donii D. Fox, Tae-Gyu Nam, Karupiah Jayaraj, Louise M. Ball, 
John E. French, David G. Klapper, Avram Gold, and Leena A. Nylander-French, Chem Res 
Toxicol. 2008 APR;21(4):852-8. 
2.1. Abstract 
To measure biomarkers of skin exposure to ubiquitous industrial and environmental 
aromatic hydrocarbons, we sought to develop an ELISA to quantitate protein adducts of 
metabolites of benzene and naphthalene in the skin of exposed individuals.  We hypothesized 
that electrophilic arene oxides formed by CYP isoforms expressed in the human skin react 
with nucleophilic sites on keratin, the most abundant protein in the stratum corneum that is 
synthesized de novo during keratinocyte maturation and differentiation.  The sulfhydryl 
groups of cysteines in the head region of the keratin proteins 1 (K1) and 10 (K10) are likely 
targets.  The following synthetic S-arylcysteines were incorporated into 10-mer head 
sequences of K1 [GGGRFSS(S-aryl-C)GG] and K10 [GGGG(S-aryl-C)GGGGG] to form the 
predicted immunogenic epitopes for antibody production for ELISA: S-phenylcysteine-K1 
(SPK1), S-phenylcysteine-K10 (SPK10), S-(1-naphthyl)cysteine-K1 (1NK1), S-(1-
naphthyl)cysteine-K10 (1NK10), S-(2-naphthyl)cysteine-K1 (2NK1), and S-(2-
naphthyl)cysteine-K10 (2NK10).  Analysis by ELISA was chosen based on its high 
throughput and sensitivity, and low cost.  The synthetic modified oligopeptides, available in 
quantity, served both as immunogens and as chemical standards for quantitative ELISA.  
Polyclonal rabbit antibodies produced against the naphthyl-modified keratins reacted with 
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their respective antigens with threshold sensitivities of 15 – 31 ng/mL and high specificity 
over a linear range up to 500 ng/mL.  Anti-S-phenylcysteine antibodies were not sufficiently 
specific or sensitive towards the target antigens for use in ELISA under our experimental 
conditions.  In dermal tape-strip samples collected from 13 individuals exposed to 
naphthalene-containing jet fuel, naphthyl-conjugated peptides were detected at levels from 
0.343 ± 0.274 to 2.34 ± 1.61 pmol adduct/µg keratin, but were undetectable in unexposed 
volunteers.  This is the first report of adducts of naphthalene (or of any polycyclic aromatic 
hydrocarbon) detected in the exposed intact human skin.  Quantitation of naphthyl-keratin 
adducts in the skin of exposed individuals will allow us to investigate the importance of 
dermal penetration, metabolism, and adduction to keratin and to predict more accurately the 
contribution of dermal exposure to systemic dose for use in exposure and risk-assessment 
models. 
2.2. Introduction 
Low molecular weight aromatic hydrocarbons are important industrial chemicals with 
significant potential for human dermal exposure (Fishbein, 1992).  A number of the lower 
molecular weight aromatics are carcinogenic to humans and laboratory rodents and have 
been associated with various disorders in humans, including hemolytic anemia and cataracts 
(IARC, 2002).  Although there is significant potential for toxicity through dermal exposure, 
there has been little investigation of possible dermal penetration and uptake, metabolism to 
reactive intermediates, and mechanisms of action of observed toxicity.  Quantitation of the 
individual dermal dose and determination of a mechanism of action hinge upon identification 
of appropriate biomarkers of exposure that can discriminate between acute and chronic 
exposure, and also on development of quantitative analytical procedures.  The only method 
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for quantitation of dermal dose of aromatic hydrocarbons reported to date (Chao et al., 2005) 
detects the unchanged parent compound on the surface of the skin, which can be attributed to 
recent exposure only.  Adducts bound to keratin would be appropriate biomarkers for chronic 
exposure, as the bioactivation required to generate adducts from aromatic hydrocarbons 
occurs only in the suprabasal level of the epidermis, where keratin is synthesized de novo.  
Approximately 20 days are required for differentiation and maturation of suprabasal 
keratinocytes (Junqueira and Carneiro, 2005) to migrate from the basal layer to form the 
stratum corneum.  Thus, periodic non-invasive sampling by tape stripping can be used to 
determine prior and cumulative chronic exposure and to provide some measure of individual 
variation in metabolic capacity. 
Cytochrome P450 isoforms observed in human skin [reviewed in (Swanson, 2004)] 
include CYP1A1, CYP1A2 and CYP2E1, which metabolize benzene and naphthalene as well 
as other polycyclic aromatic hydrocarbons (Seaton et al., 1994; Gut et al., 1996) to arene 
oxides (Chichester et al., 1994).  These reactive electrophiles (Figure 2.1) can form protein 
adducts with the nucleophilic sulfhydryl group of cysteine residues.  Thus systemic exposure 
to benzene gives rise to adducts of benzene oxide at the cysteinyl residues of albumin and 
globin in rats and humans (Bechtold et al., 1992; Melikian et al., 1992; McDonald et al., 
1994; Rappaport et al., 1996; Yeowell-O'Connell et al., 1998; Rombach and Hanzlik, 1999), 
while protein adducts of naphthalene-1,2-oxide at cysteine residues have been demonstrated 
in mice exposed via intraperitoneal injection (Buckpitt and Warren, 1983; Zheng et al., 1997)  
Protein adducts of bioactivated sulfonamides have been detected in cultured human 
keratinocytes by qualitative ELISA (Vyas et al., 2006).  We hypothesized that dermal 
exposure to benzene and naphthalene would lead to formation of adducts at cysteine 
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sulfhydryl groups in keratinocyte proteins through activation by CYP isoforms in the 
suprabasal layer where keratin is synthesized de novo and xenobiotic metabolism most likely 
occurs during differentiation and maturation.  We further hypothesized that the most 
accessible nucleophilic targets would be within the N-terminal head regions of type II keratin 
K1 and type I keratin K10 proteins.  K1 and K10 are present in abundance in the stratum 
corneum here they are associated as 1:1 heterodimers in intermediate filaments with the N-
terminal domains protruding from the filament surface (Albers and Fuchs, 1992).  We 
considered that adduction would occur predominantly at cysteine sulfhydryl groups, although 
other highly nucleophilic residues, particularly arginine residues close to the N terninus of 
K1, could also be targets.  Arene oxide adducts formed at the cysteine residues of newly 
synthesized K1 and K10 would be of interest for quantitation as biomarkers of dermal 
exposure at steady rates of xenobiotic metabolism and as initial events leading to possible 
toxic reactions (e.g., delayed type IV hypersensitivity). 
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Figure 2.1. Putative pathway for benzene and naphthalene metabolism and adduction of 
keratin. 
We selected cysteine-containing 10-mers in the head sequences of K1 and K10 
closest to the protein N terminus as likely sites for adduct formation prior to keratin folding 
and compaction in the corneocyte (Rieger and Franke, 1988): the K1 10-mer head sequence 
comprised of residues 42-51 (GGGRFSSC*GG) (UniProtKB/TrEMBL) and the K10 10-mer 
head sequence comprised of residues 21-30 (GGGGC*GGGGG), where *C represents the 
modified cysteine (UniProtKB/TrEMBL).  A similar strategy was applied to develop 
immunochemical analyses for sulfur mustard adducts at glutamine and asparagine residues of 
K1, K5, and K14 head groups (van der Schans et al., 2002).  However, this report is distinct 
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from our study in that the sulfur mustard adducts are formed by direct reaction of 
electrophiles that do not require metabolic activation. 
On the basis of studies of nucleophilic addition of the sulfhydryl group to arene 
oxides  (Jeffrey et al., 1974; Bruice et al., 1976; Zheng et al., 1997), the cysteine residues 
would be predicted to react with benzene oxide to give initially the vicinal trans-S-(1,2-
dihydro-1-hydroxy-2-phenyl)-cysteine adduct and to react with naphthalene-1,2-oxide 
predominantly at C2  to yield initially the trans-S-(1,2-dihydro-1-hydroxynaphth-2-
yl)cysteine adduct, although the regioisomer from attack at C1 has been reported in 
significant proportion from the reaction of naphthalene-1,2-oxide with glutathione 
(Chichester et al., 1994), hemoglobin, and albumin (Yeowell-O'Connell et al., 1998).  
Initially formed vicinal S-(dihydrohydroxyaryl)cysteine adducts of arene oxides undergo 
facile dehydration to the aromatized S-aryl cysteines (Marco et al., 1993).  In the 
physiologically normal acidic environment of the skin at pH 4-5 (Fluhr et al., 2002; Choi et 
al., 2007), the S-aryl adducts were deemed the form most likely to be present and detected in 
our analysis.  Hence, our synthetic targets were the S-phenyl-, S-naphth-1-yl- and S-naphth-
2-yl-cysteine-modified keratin sequences.  Availability of chemically defined haptens 
allowed development of a quantitative ELISA, in contrast to previous studies (Vyas et al., 
2006).  We incorporated the appropriately modified, 9-fluorenylmethoxycarbonyl (Fmoc)-
protected cysteines into the 10-mers by solid-phase peptide synthesis as the most practical 
scheme to obtain the putative haptens in quantity.  We prepared the pure, rigorously 
characterized S-aryl haptens by a procedure published by our laboratory (Gold et al., 2003) 
for conjugation to carrier protein (keyhole limpet hemocyanin, KLH) and production of 
rabbit polyclonal antibodies for ELISA development.  The affinity purified polyclonal 
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antibodies were tested for their sensitivity and specificity to detect keratin adducts formed by 
the benzene and naphthalene oxides in the skin samples collected from occupationally 
exposed workers.  The sampling strategy was based on an adaptation of a quantitative tape-
strip method developed for non-invasive dermal sampling, which we have used to measure 
dermal deposition of acrylates (Nylander-French, 2000), isocyanates (Fent et al., 2006; Flynn 
et al., 2006), and naphthalene (Chao et al., 2005; Chao et al., 2006; Kim et al., 2006a; Kim et 
al., 2006b; Kim et al., 2007). 
2.3. Materials and Methods 
2.3.1. Modified Oligopeptides 
Synthesis and characterization of the Fmoc-protected S-aryl cysteines and the 
modified K1 and K10 sequences have been described previously (Gold et al., 2003).  The 
specific targets for synthesis were the 10-mer head sequence comprised of residues 42-51 
GGGRFSS(S-aryl-C)GG for K1 (UniProtKB/TrEMBL) and 10-mer head sequence 
comprised of residues 21-30 GGG(S-aryl-C)GGGGG for K10 (UniProtKB/TrEMBL).  For 
ease of conjugation of the modified peptides to KLH, S-(1-naphthyl)cysteine-modified K1 
and K10 peptides (1NK1, 1NK10) and S-(2-naphthyl)cysteine-modified K1 and K10 
peptides (2NK1, 2NK10) were synthesized with lysine substituted for the N-terminal glycine 
(Table 2.1).  The purity of the peptides was determined to be >98% by HPLC analysis. 
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Table 2.1. Keratin head sequences modified at cysteine by arene oxides. 
Modified K1 10-Mers Modified K10 10-Mers 
SPK1 GGGRFSS(S-phenyl-C)GG SPK10 GGGG(S-phenyl-C)GGGG 
1NK1 
KGGRFSS[S-(1-naphthyl)-C]GG 
LOS
1
 31.25 ng/mL 
1NK10 
KGGG[S-(1-naphthyl)-C]GGGGG 
LOS
1
 31.25 ng/mL 
2NK1 
KGGRFSS[S-(2-naphthyl)-C]GG 
LOS
1
 15.63 ng/mL 
2NK10 
KGGG[S-(2-naphthyl)-C]GGGGG 
LOS
1
 31.25 ng/mL 
1
 LOS = limit of sensitivity of ELISA using polyclonal antibodies against the specific antigen. 
2.3.2. Production of Polyclonal Antibodies 
The S-aryl cysteine-modified peptides were conjugated to KLH (Pierce Chemical, 
Rockford, IL) by the glutaraldehyde cross-linking procedure.  Equal weights of peptide and 
KLH in phosphate-buffered saline (PBS) were mixed by vortexing with addition of 
glutaraldehyde (Sigma-Aldrich, St. Louis, MO) to a final concentration of 0.25%.  Rabbits 
(two Flemish Giants per antigen; Bethyl Laboratories, Inc., Montgomery, TX) were 
immunized by subcutaneous injection into four separate sites with 100 g of KLH-
conjugated peptide dissolved in PBS (0.3 mL) and emulsified in an equal volume of 
complete Freund’s adjuvant.  Two booster immunizations at 2-week intervals with peptide-
KLH complex in incomplete Freund’s adjuvant completed the immunization.  Seven days 
after the final booster, the animals were anesthetized, exsanguinated, and euthanized 
following standard protocols approved by the Bethyl Laboratories’ Institutional Animal Care 
and Use Committee.  Sodium azide was added to antisera as an antimicrobial.  Antibody 
titers were verified using ELISA by coating peptide antigen onto microtiter wells and 
reacting with dilutions of antisera (dilution range 1:200 to 1:114,670), followed by antirabbit 
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IgG/horseradish peroxidase and 3,3′,5,5′-tetramethyl benzidine (TMB) substrate.  Antisera 
were stored at –20C until purification. 
2.3.3. Immunoaffinity Purification of Antibodies 
Antisera were purified using Econo-Pac DEAE Blue (Bio-Rad Laboratories, 
Hercules, CA) and affinity column chromatography at room temperature.  The DEAE with 
Cibacron Blue resin was used to remove serum albumin and other serum proteins.  The 
column was washed with regeneration buffer (1.4 M NaCl, 0.1 M acetic acid, pH 3.0, 40% 
v/v isopropanol) and equilibrated with application buffer (0.028 M NaCl and 0.020 M Tris-
HCl, pH 8.0).  Each antiserum was diluted with an equal volume of the application buffer 
then loaded onto the column, and the fall-through was collected.  The column was washed 
with elution buffer (1.4 M NaCl and 0.020 M Tris-HCl, pH 8.0) followed with regeneration 
buffer.  The column was equilibrated with application buffer before reuse.  The fall-through 
material from the DEAE Blue purification step from multiple aliquots of the same antiserum 
was pooled and concentrated with an iCON concentrator (Pierce).  Eight antigen-specific 
immunoaffinity columns were prepared by solid phase synthesis of the peptides SPK1, 
SPK10, 1NK1, 2NK1, 1NK10, 2NK10, unmodified K1, and unmodified K10 on an amino-
containing resin (ToyoPearl AF-Amino-650M, Tosoh Bioscience, Montgomeryville, PA).  
Individual immunoadsorbants where each peptide is linked at its carboxyl terminus to the 
resin via an uncleavable linker were prepared.  Before use, each column was equilibrated 
with binding buffer containing Tris-buffered saline (Bio-Rad) with 0.5 M sodium chloride 
(Sigma-Aldrich).  The concentrated DEAE fall-through was loaded onto the corresponding 
column followed by the binding buffer containing Tris- buffered saline.  The antibody 
fraction was eluted from the column with 5% glacial acetic acid (Fisher Scientific, 
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Pittsburgh, PA).  Each fraction exhibiting absorbance at 280 nm (UA-6 absorbance detector, 
ISCO, Lincoln, NE) was collected and neutralized with 1M Tris base solution (Boehringer 
Mannheim Corp., Indianapolis, IN) and then concentrated with an iCON concentrator.  The 
affinity column-purified antibodies were cross-absorbed onto a K1 or K10 column to remove 
K1 or K10 cross-reactivity, respectively.  The fall-through was collected and dialyzed against 
PBS overnight at 4C using 10-mm dialysis tubing (MW 12,000-14,000; Spectrum 
Spectra/Por, Spectrum Laboratories, Inc., Rancho Dominquez, CA).  Antibodies were 
concentrated with the iCON concentrator and quantitated using a bicinchoninic acid (BCA) 
protein assay (Pierce). 
2.3.4. Enzyme-linked Immunosorbent Assay (ELISA) 
After optimization of each antigen-specific ELISA, the general procedure for ELISA 
was as follows.  A polystyrene 96 microwell plate (Nalgene Nunc International, Rochester, 
NY) was coated by addition of 100 µL of a serial dilution of an antigen standard or a 
potential cross-reactive antigen (K1, K10, KLH), or bovine serum albumin (BSA, an 
unrelated antigen), starting at 500 ng antigen/mL to no antigen in Voller’s buffer (100 mM 
sodium bicarbonate) to a well (in replicate), sealed, and incubated at 4C overnight.  The 
plates were washed four times with 250 L of 0.1% Tween 20 in PBS (PBST) and incubated 
for 1 h with 150 µL of blocking buffer (5% skim milk in PBST) at 37C to prevent 
nonspecific binding of subsequent reagents.  The plates were washed as described above and 
100 µL of each affinity-purified antibody with the final optimized concentration of 0.8 (for 
1NK1) or 7 µg/mL (for SPK1, SPK10, 1NK10, 2NK1, and 2NK10) in PBST was added to 
the appropriate plate and incubated for 1 h at 37C.  The plates were washed again and 100 
µL of a 1:4000 dilution of goat antirabbit horseradish peroxidase (HRP) conjugate was 
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added.  The plates were incubated for 1 h, washed, and 100 µL of TMB-ELISA substrate 
(Pierce) was added and allowed to react at room temperature for 30 min.  The reaction was 
stopped by adding 100 µL of 2 M sulfuric acid and absorbance was determined at 450 nm 
(Emax, Molecular Devices, Sunnyvale, CA). 
2.3.5. Skin Samples From Occupationally Exposed Workers and Unexposed Controls 
Dermal tape-strip samples were obtained from 13 active duty US Air Force fuel-cell 
maintenance workers who were routinely exposed to naphthalene- and benzene-containing 
jet fuel while performing their duties.  Dermal samples were also collected from four 
individuals who declared that they had not knowingly been exposed to naphthalene (exposure 
control).  This study was approved by the Institutional Review Board in the Office of Human 
Research Ethics at the University of North Carolina at Chapel Hill.  The average age of the 
subjects was 22 ± 3.9 years and 12 were male.  The median naphthalene concentration in the 
dermal samples was 53 µg/m
2
 (range: 3 – 5,086 µg/m2).  Exposure conditions, sample 
collection, and analysis have been described previously (Chao et al., 2005).  In brief, tape-
strip samples were collected with adhesive tape strips (2.5 cm  4.0 cm, Cover-Roll™, 
Beiersdorf AG, Germany) from the volar region of the right arm after the work shift.  Tape 
was applied to the skin surface with a constant pressure; after 1 min, it was removed at 
approximately a 45
o
 angle.  Three tape strips were collected sequentially from the exposed 
site.  The tape was rolled with the adhesive side facing out and placed into a 2 mL cryovial.  
Samples were stored at –80ºC until the collected protein was extracted and quantified by 
Bradford assay and keratin adduct quantified by ELISA. 
2.3.5.1. Protein Quantitation 
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Three sequential tapes collected from each of the exposed sites were pooled and 
treated with 3 mL of extraction solution (8 M urea, 50 mM Tris, 0.1 M -mercaptoethanol, 
0.1% sodium azide), vortexed for 15 s, and placed on a shaker overnight at 150 rpm.  Sample 
(100 µL) was placed into a cuvette, and 1 mL of Bradford reagent (Amresco Inc., Solon, OH) 
was added to each, vortexed, and read at 595 nm (Cary 100, Varian Instrument Co, Palo 
Alto, CA) (Bradford, 1976).  The keratin concentration of each sample was determined by 
interpolation and reference to a standard curve constructed from serial dilutions (0 - 500 
µg/mL) of human epidermal keratin dissolved in urea (30 mg/mL)(Sigma-Aldrich).  Our 
published report has established that keratins 1 and 10 are the major proteins removed from 
the human stratum corneum by tape stripping (Chao et al., 2004). 
2.3.5.2. Keratin Adduct Quantification in the Skin Samples Collected from 
Occupationally Exposed Workers and Unexposed Controls 
ELISA was performed as described above using the antigens SPK1, SPK10, 1NK1, 
2NK1, 1NK10, and 2NK10 as standards.  Each individual standard antigen (in duplicate) was 
diluted 1:2 in Voller’s buffer per well across the plate starting at 500 ng/mL (0 – 500 ng/mL).  
Each exposed individual’s sample was coated onto a separate well on the same plate in 
triplicate, along with a separate control sample (exposure control), composed of a pooled 
tape-strip sample of keratin extract collected from four individuals who had not knowingly 
been exposed to naphthalene.  For antigen adsorption to the well, the plates were incubated 
overnight, washed, and blocked.  Affinity-purified rabbit polyclonal antibodies (against 
1NK1, 1NK10, 2NK1, and 2NK10 haptens) at dilutions of 0.8 (1NK1) or 7 µg/mL (1NK10, 
2NK1, and 2NK10) were used as the primary antibodies for adduct detection.  The plates 
were incubated and washed as described above.  Secondary antibody (1:4000 dilution) goat 
antirabbit HRP-conjugate was added to each well, and the plates were washed and incubated 
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with TMB-ELISA substrate.  The reaction was terminated, and the absorbance read at 450 
nm.  The amount of each keratin adduct in each sample was determined based on the 
standard curve constructed using each synthetic antigen, adjusted for the reading of the 
exposure control samples [i.e., average background of unexposed samples was subtracted].  
The adduct level was then normalized based upon the amount of keratin recovered from each 
tape-strip sample.  The limit of detection was determined using a 2-fold increase relative to 
the mean of the Voller’s buffer negative control. 
2.4. Results 
2.4.1. Sensitivity and Specificity of the Purified Antisera 
The six hapten-specific affinity-purified polyclonal antibodies produced (Table 2.1) 
were tested for sensitivity against their specific target antigens as well as for specificity 
against other target antigens and the four potential cross-reactive antigens K1, K10, KLH, 
and BSA (an unrelated antigen) (Figures 2.2A-F).  The results showed that the 3-step 
purification produced polyclonal antibodies specific to antigens 1NK1, 2NK1, and 2NK10 
with threshold sensitivities of 31.25, 15.63, and 31.25 ng/mL, respectively, over a linear 
range up to 500 ng/mL (R
2
 = 0.96, 0.99, and 0.99, respectively).  The three affinity-purified 
antinaphthyl-keratin antibodies also showed low cross-reactivity against all other antigens 
(Figures 2.2A, B, D).  The affinity-purified anti-1NK10 antibody had a sensitivity of 31.25 
ng/mL against 1NK10, however, it also cross-reacted with antigen 1NK1 (Figure 2.2C).  This 
antibody preparation reacts specifically against the S-(1-naphthyl) moiety but cannot 
discriminate between an adduct on K1 or K10.  Nevertheless, it can still be used to detect 
adducts of 1-naphthyl-modified K10 by subtracting the reading for 1NK1 from the total. 
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The purified antibody to SPK1 showed high specificity to synthetic SPK1, but it also 
cross-reacted with antigens K1 and 1NK1 (Figure 2.2E) indicating the significant presence of 
antibodies to other epitopes that were not removed by purification.  The purified SPK10 
antibody also recognized antigens 1NK10 and 2NK1 while exhibiting low sensitivity toward 
its target antigen SPK10 (Figure 2.2F), suggesting an epitope specificity problem similar to 
that of SPK1.  Consequently, neither of the antibodies to SPK1 or SPK10 produced under the 
reported conditions is suitable for detection and quantification of S-phenylcysteine-
containing adducts.  The strategy and protocol for production of the S-phenylcysteine-
modified keratins will be reevaluated and additional studies performed to produce either 
monoclonal or polyclonal antibodies for the synthetic epitopes. 
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Figure 2.2. Sensitivity and specificity of purified antibodies against (A) 1NK1, (B) 2NK1, 
(C) 1NK10, (D) 2NK10, (E) SPK1 and (F) SPK10.  Each purified antibody (0.8 
µg/mL of 1NK1; 7 µg/mL of 1NK10, 2NK1, 2NK10, SPK1, or SPK10) was 
reacted against 0 – 500 ng/mL serial dilutions of its intended target antigen and 
other potential cross-reactive antigens. 
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2.4.2. Keratin Adduct Quantification in the Skin Samples Collected From 
Occupationally Exposed Workers and Unexposed Controls  
Keratin protein quantities in the tape-strip skin samples collected from the 13 
occupationally exposed workers ranged from 16.8 to 236.4 µg/mL, with a mean value ± 
standard deviation of 115.0 ± 70.0 µg/mL.  The variation in amount of keratin recovered 
between individuals may be due to the difference in perspiration and other individual factors 
affecting adhesion and removal of the tape.  Hence, quantification of adducts is adjusted for 
the quantity of keratin removed in each skin sample.  The four naphthyl-keratin adducts were 
detected in the tape-stripped skin samples at levels from 0.047 to 6.85 pmol/µg keratin 
(Figure 2.3).  The highest levels of adduct were observed for 2NK10 and the lowest for 
2NK1.  The mean naphthyl-keratin adduct levels ± standard deviations were 0.343 ± 0.274 
(1NK1), 1.77 ± 1.13 (1NK10), 0.343 ± 0.494 (2NK1), and 2.34 ± 1.61 (2NK10) pmol 
adduct/µg keratin.  No correlation was observed between naphthyl-keratin adduct 
concentrations and dermal naphthalene levels measured in this sample population (Chao et 
al., 2005) (data not shown).  Mean levels of the total naphthyl-bound K1 (1NK1 + 2NK1) 
were significantly lower than the total naphthyl-bound K10 (1NK10 + 2NK10) using the 
Student’s t-test (p < 0.001).  Significant differences were also found between the mean levels 
of 1NK10 and 2NK10 (p <0.0001) but not between 1NK1 and 2NK1 using the Student’s t-
test (p = 0.1155).  No adducted keratins were observed in unexposed (negative control) 
individuals. 
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Figure 2.3. Quantitation of naphthyl-keratin adducts in tape-strip samples collected from 13 
workers occupationally exposed to jet fuel.  The top error bar represents the 
maximum value while the bottom error bar represents the minimum value.  The 
top of the box represents the 75
th
 percentile while the bottom represents the 25
th
 
percentile.  The line in the box represents the median. 
2.5. Discussion 
The lack of correlation between keratin adduct and dermal naphthalene levels was not 
unexpected since dermal naphthyl-keratin adduct concentration reflects the cumulative 
exposure and inter-individual variation of CYP metabolic activity, whereas dermal 
naphthalene levels reflect only the most recent exposure (i.e., exposure received on the day 
of sampling).  The significant differences in adduct levels between keratin 1 and keratin 10 
was surprising at first since evidence supports the basic unit of the intermediate filament to 
be 1:1 ratio between type I (K10):type II (K1) keratin heterodimer.  However, effects of the 
imbalance in K1:K10 levels on filament structure cannot be ruled out (Albers and Fuchs, 
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1992) and is also currently unknown.  In addition, down-regulation of type II keratins (K1) 
and up-regulation of type I keratins (K10) was observed in human keratinocyte cell cultures 
exposed to JP-8 jet-fuel (Witzmann et al., 2005) although the mechanism leading to the 
altered keratin expression levels is currently unknown.  It is not apparent whether the 
difference in adduct levels represents a direct reflection of an increased level of monomeric 
K10, the result of a difference in cysteine sulfhydryl accessibility attributable to structure in 
the intermediate filaments, or simply less accessibility of the target cysteine of K1 as a result 
of location further from the N-terminal of the protein and competitive adduction at an 
arginine-rich region of K1 closer to the N-terminal.  Significant differences were found 
between the mean levels of 1NK10 and 2NK1 (p < 0.0001) but not between 1NK1 and 2NK1 
using the Student’s t test (p = 0.1155).   This finding is intriguing but should not be over-
interpreted as the sample size is limited and binding levels to K1 are low. 
In summary, we have developed methods for specific antigen synthesis, antibody 
purification, and ELISA for quantitation of naphthyl-keratin adducts as biomarkers of dermal 
exposure to naphthalene.  This is the first report of the detection and quantitation of 
polycyclic aromatic hydrocarbon adducts formed in the skin of exposed humans in vivo, and 
is consistent with our observation of adduct formation in vitro with reconstructive skin 
(unpublished).  Previous reports only addressed adducts formed by direct-acting chemicals or 
adducts formed in vitro.  Our approach also allows for direct quantitation of adduct levels, as 
opposed to qualitative assessment of intensity or staining or fluorescence (Vyas et al., 2006).  
Quantitation of keratin adducts obtained from the stratum corneum of exposed individuals 
will allow us to investigate the importance of dermal penetration, metabolism, and adduction 
to keratin as well as to make accurate prediction of the contribution of dermal exposure to the 
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systemic dose for inclusion in exposure- and risk-assessment models.  This study confirms 
that our approach of chemical synthesis of predicted epitope-specific antigens combined with 
sensitive ELISA should be adaptable for use with other low and high molecular weight aryl 
hydrocarbons or other electrophilic species, whether direct-acting or formed as a result of 
bioactivation.  By studying the binding occurring in the viable epidermis and presented in the 
stratum corneum available for noninvasive sampling, we will be able to investigate both 
external and internal factors contributing to keratin protein adduction during dermal 
exposure, including exposure dosages, use of personal protective equipment, and individual 
differences in xenobiotic metabolism.  The ability to quantitate keratin adducts as biomarkers 
of dermal exposure will enable us to distinguish systemic dose resulting from dermal 
exposure from other routes of exposure.  Correlation of individual adduct levels with the 
CYP isoform single nucleotide polymorphisms (SNPs) among individuals in sample 
population will contribute toward establishing the role of SNPs in interindividual 
susceptibility to exposures.
 
 
Chapter 3 
3. Exposure to naphthalene induces naphthyl-keratin adducts in human epidermis in 
vitro and in vivo 
Juei-chuan C. Kang-Sickel, Vandy P. Stober, John E. French, Leena A. Nylander-French. 
Biomarkers 2010 MAY 25, DOI: 10.3109/1354750X.2010.485700. 
3.1. Abstract 
We observed naphthyl-keratin adducts and dose-related metabolic enzyme induction 
at the mRNA level in reconstructed human epidermis in vitro after exposure to naphthalene.  
Immunofluorescence detection of 2-naphthyl-keratin-1 adducts confirmed the metabolism of 
naphthalene and adduction of keratin.  We also observed naphthyl-keratin adducts in dermal 
tape-strip samples collected from naphthalene-exposed workers at levels ranging from 0.004 
to 6.104 pmole adduct/µg keratin.  We have demonstrated the ability of the human skin to 
metabolize naphthalene and to form naphthyl-keratin adducts both in vitro and in vivo.  The 
results indicate the potential use of keratin adducts as biomarkers of dermal exposure. 
3.2. Introduction 
Human skin is a large and structurally complex organ of many layers, which 
possesses different biological properties and characteristics. Keratinocytes in the basal layer 
proliferate and start differentiating and migrating to the surface to form the stratum corneum, 
which takes approximately four weeks (Furukawa et al., 2008).  The differentiating basal 
keratinocytes express various differentiation markers, including large amounts of keratin 1 
(K1) and keratin 10 (K10) proteins (Schweizer and Winter, 1983; Eichner et al., 1986).  The 
cells increase in size once they enter the spinous layer and migrate further into the granular 
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layer, at which time all the cytoplasmic organelles are eliminated, and the keratins become 
the principal proteins in the cytoplasm (Fuchs and Green, 1980; Albers and Fuchs, 1992).  
Keratinocytes in the epidermis contains a myriad of transport and metabolic enzymes 
providing active uptake and biotransformation of many xenobiotics, such as polycyclic 
aromatic hydrocarbons (PAHs) (Baron and Merk, 2001; Gibbs et al., 2007).  PAHs absorbed 
into the skin layer are metabolized to electrophiles, which may adduct nucleophilic sites on 
keratin proteins while keratinocytes differentiate, mature, and migrate upward to the stratum 
corneum (Watt, 1988b).  We hypothesized that these metabolites are likely to adduct the 
nucleophilic cysteine residues on the head region of the N-terminal of K1 and K10 proteins, 
which are the preferred adduction sites on proteins, albumin, and hemoglobin (Yeowell-
O'Connell et al., 1996; Waidyanatha et al., 2002) when co-expressed in the suprabasal layer 
of the epidermis. 
Naphthalene, the simplest form of a PAH, is a widely used industrial chemical and is 
a major constituent in jet fuels (JP-8) (McDougal et al., 2000) to which humans are 
environmentally and occupationally exposed.  Naphthalene exposure has become a 
significant health concern due to evidence for its carcinogenic properties in mice and rats 
(NTP, 2000; North et al., 2008).  This has propelled several agencies to classify naphthalene 
as a possible human carcinogen (US EPA, 1998; NTP, 2000; IARC, 2002; DFG, 2008).  
Naphthalene toxicity is also associated with other disorders, such as hemolytic anemia in 
children (Zinkham and Childs, 1958; Santhanakrishnan et al., 1973), cataracts (Ghetti and 
Mariani, 1956), and laryngeal tumors (Wolf, 1978).  Although there are many hydrocarbon 
species in the JP-8 mixture, naphthalene has been successfully established as the surrogate 
marker for jet-fuel (JP-8) exposure from both inhalation (Egeghy et al., 2003) and dermal 
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(Chao et al., 2006; Kim et al., 2007) exposure routes.  Furthermore, few chemicals had been 
shown to have the same potency as naphthalene to form reactive metabolites that covalently 
bind to various macromolecules, such as albumin and hemoglobin (Waidyanatha et al., 
2002).  Naphthalene metabolites in urine and their adduction to albumin have also been 
established as biomarkers of JP-8 and other PAH exposure (Serdar et al., 2004; Waidyanatha 
et al., 2004).  Multiple studies have shown the existence of several cytochrome P450s 
isoforms in the skin, which is a major family of enzymes that metabolize endogenous 
substrates, drugs, and xenobiotics (Janmohamed et al., 2001; Saeki et al., 2002; Yengi et al., 
2003; Du et al., 2004).  Naphthalene is quickly absorbed through the epidermis (Kim et al., 
2006a), due to its hydrophobicity and small molecular weight, and may be metabolized by 
P450 enzymes associated with PAH metabolism, such as 1A1, 1A2, 1B1, 2E1, and 3A5 
(Gabbani et al., 1999; Godschalk et al., 2001; Lee et al., 2001; Shimada, 2006).  We 
hypothesized that naphthalene exposure induces the expression of P450 enzymes in the skin, 
which transform naphthalene to reactive electrophilic molecules (e.g., naphthalene epoxide).  
These molecules may react with the sulfhydryl group of the cysteine residue in the head 
region of K1 and K10 expressed de novo in the viable epidermis, forming 1-naphthyl–K1 
(1NK1), 2-naphthyl–K1 (2NK1), 1-naphthyl–K10 (1NK10), or 2-naphthyl–K10 (2NK10) 
adducts. 
To investigate the potential for the formation of these naphthyl-keratin adducts in the 
skin of exposed individuals, we developed specific polyclonal antibodies and enzyme-linked 
immunosorbent assays (ELISA) to detect 1- and 2-naphthyl-keratin adducts (Kang-Sickel et 
al. 2008).  Here, we investigated the effects of dermal exposure to naphthalene at the 
molecular level using three-dimensional (3D) reconstructed human skin in vitro and in situ 
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immunofluorescence, and then in vivo using specific ELISAs developed previously to 
analyze tape-strip samples collected from U.S. Air Force (USAF) personnel, who were 
routinely exposed to naphthalene-containing jet-fuel (JP-8).  We also validated the approach 
of utilizing ELISA to quantitatively measure these adducts, which will facilitate investigation 
of naphthalene/JP-8 exposure assessment, particularly regarding dermal contact. 
3.3. Materials 
3.3.1. In vitro Human Epidermis 
The 3D human skin tissue reconstruct (EFT-300, MatTek, Ashford, MA) is a 
commercially available in vitro skin model.  EFT-300 is a full-thickness skin model that 
consists of normal, human-derived epidermal keratinocytes and fibroblasts to form a multi-
layered, well-differentiated skin model.  It contains stratum corneum, epidermis, and dermis, 
and is metabolically active, thus, making it a suitable in vitro tool for skin toxicology studies.  
The tissue constructs on cellulose membrane support and insert with the appropriate air-
liquid interface were cultured in 6-well plates containing 1 mL of fresh media in each well.  
Upon arrival to the laboratory, the tissue constructs were placed in a 37ºC, 5% CO2 incubator 
overnight for equilibration.  Before each new media exchange and naphthalene exposure, the 
used media was aspirated and 1 mL of fresh, pre-warmed media was added into each well 
below the tissue insert.  Based upon preliminary dose range-finding studies, four skin inserts 
were treated every other day for each of the six treatment groups: untreated, vehicle only 
(acetone), 0.02 nmol, 0.2 nmol, 2 nmol, or 20 nmol of naphthalene per well for each 
exposure.  After three repeated exposures every other day, the reconstructed skin was 
removed from the insert, and tissues from each of the six treatment groups were collected for 
viability study and determination for gene expression (cDNA microarray).  In addition, to 
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demonstrate the capacity of human skin to metabolize naphthalene and to form naphthyl-
keratin adducts, one tissue from each of the six treatment groups was collected for 
hematoxylin and eosin (H&E) staining and immunofluorescence microscopy. 
3.3.1.1. Viability 
One skin insert from each treatment group was washed with phosphate buffered 
saline (PBS) three times and placed into a clean plate containing 300 µL of MTT agent 
(MatTek) and incubated at 37ºC for 3 hr.  At the end of incubation, each skin insert was 
transferred into a fresh plate containing 2 mL of MTT extraction solution and placed on a 
shaker for 2 hr.  An aliquot of each extracted sample solution (200 µL) was placed into a new 
plate and the optical densities were measured at 570 nm and the background readings 
subtracted at 650 nm (Mosmann, 1983). 
3.3.1.2. RNA Expression 
The epidermal tissue was homogenized, and the total RNAs were isolated using 
Qiagen RNeasy protocol.  Quantified total RNA (250 ng) was amplified and SuperArray HS-
019 Human GEArray series Q arrays (Cat. No. HS-019, Bioscience Corp., Frederick, MD) 
were used to determine the relative expressions of genes that are considered relevant to skin 
metabolism of endogenous and exogenous substrates.  RNA (5 µg) was used to generate 
biotin-16-dUTP-labeled cDNA probes according to manufacturer’s instructions.  The cDNA 
probes were denatured and hybridized at 60ºC with the SuperArray membrane, which was 
washed and exposed with chemiluminescent substrate.  Acetone is an endogenous substrate 
for CYP2E1, and was used as a delivery vehicle in vitro for naphthalene.  Therefore, the 
mRNA transcription profile data were normalized against the acetone control to deduct the 
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proportion of expression induced by the vehicle, as well as the housekeeping gene, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), to control for differences between 
samples (Fluorchem 8900, Alpha Innotech, San Leandro, CA). 
3.3.1.3. Immunohistochemistry/immunofluorescence 
One tissue from each of the six treatment groups was placed in a histology cassette 
and fixed in 60% of ethanol, 30% water, and 10% formalin (37% formaldehyde solution), for 
2–4 hr, and then fixed with 70% ethanol overnight at 4ºC.  The tissues were then dehydrated, 
embedded in paraffin, and sectioned.  The tissue sections were deparaffinized and dehydrated 
through a series of ethanol.  Antigen retrieval was performed using citrate buffer and the 
sections were blocked with 1X Autobuffer (Biomeda, Foster City, CA).  The affinity-purified 
rabbit anti-2NK1 antibody (Kang-Sickel et al., 2008) was applied onto the tissue section and 
incubated in the dark for one hour.  After rinsing with PBS, the secondary antibody, Alexa 
Fluor 546 conjugated chicken anti-rabbit IgG (Molecular Probe) was applied and incubated 
in the dark for one hour.  The sections were washed 3 times in 1X PBS, coverslipped with 
Vectashield Hard Set mounting medium with DAP-1 stain, and images captured under the 
inverse microscope (Olympus IX70) with camera (Sony DXC-s 500) (Ponec et al., 2002). 
3.3.2. Detection of Naphthyl-Keratin Adducts in the Skin of Occupationally Exposed 
Workers 
Dermal tape-strip samples were obtained from 105 fuel-cell maintenance workers 
exposed to jet fuel (JP-8) at five USAF bases (described in Chao et al., 2005).  Dermal 
samples were collected post-exposure using adhesive tape-strips (2.5 cm  4.0 cm, surface 
area 10 cm
2
 Cover-Roll
TM
, Beiersdorf AG, Germany) from 3–5 exposed body regions and 
three sequential tapes were collected from each site.  Each tape was applied onto the skin 
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surface with a constant pressure and removed at approximately 45-degree angle after one 
minute.  The tape was rolled with the adhesive side facing out and placed into a 2-mL 
cryovial and stored in –80C until further analysis.  Dermal samples were also collected from 
individuals who declared that they had not been exposed to naphthalene or jet-fuel (exposure 
controls).  The study was approved by the Institutional Review Board in the Office of Human 
Research Ethics at the University of North Carolina at Chapel Hill.  Participation of the 
human subjects did not occur until after informed consent was obtained. 
3.3.2.1. Keratin Protein Quantitation 
Three sequential tapes collected from one exposed site were pooled and extracted 
with 3 mL of the extraction solution (8 M urea, 50 mM Tris, 0.1 M b-mercaptoethanol, 0.1% 
sodium azide), vortexed for 15 sec, and placed on a shaker overnight at 150 rpm.  The 
Bradford assay was performed using human epidermis keratin solution (Sigma-Aldrich) as 
standard with serial dilution from 500 µg/mL.  Each sample (100 µL) was placed into a 
cuvette and 1 mL of Bradford reagent (Amresco Inc., Solon, OH) was added, vortexed, and 
read at 595 nm (Cary 100, Varian Instrument Co, Palo Alto, CA).  The keratin concentration 
of each sample was determined by interpolation and reference to a standard curve (Kang-
Sickel et al., 2008).  The remaining sample from each extraction is used for adduct 
quantitation using ELISA described below. 
3.3.2.2. ELISA for Adduct Quantitation 
The sensitivities and specificities of the antibodies used in ELISA were tested and 
validated previously, and a standard curve was developed for each of the four naphthyl-
keratin adducts (1NK1, 2NK1, 1NK10, 2NK10) (Kang-Sickel et al., 2008).  The ELISA for 
adduct quantitation was performed by coating polystyrene plates with 100 µL of a serial 
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dilution of an antigen standard (1NK1, 2NK1, 1NK10, 2NK10), starting at 500 ng 
antigen/mL in Voller’s buffer (100 mM sodium bicarbonate) to a well (in replicate).  The 
extracted tape-strip samples were coated in triplicates, along with samples collected from 
individuals not exposed to JP-8 (exposure controls), on the same plate, sealed, and incubated 
at 4C overnight.  The plates were washed 4 times with 250 µL of 0.1% Tween 20 in PBS 
(PBST) and incubated with 150 µL of blocking buffer (5% skim milk in PBST) at 37C to 
prevent non-specific binding of subsequent reagents.  The plates were washed as described 
above and 100 µL of each affinity-purified antibody ranging from 0.8 to 7 µg/mL in PBST 
was added to the appropriate plate and incubated for 1 hr at 37C.  The plates were washed 
again and 100 µL of a 1:4000 dilution of goat anti-rabbit HRP-conjugate was added.  The 
plates were incubated for 1 h, washed, and 100 µL of TMB-ELISA substrate (Pierce) was 
added and allowed to react at room temperature for 30 min.  The reaction was stopped by 
adding 100 µL of 2 M sulfuric acid and absorbance determined at 450 nm (Emax, Molecular 
Devices, Sunnyvale, CA).  The amount of keratin adduct in each sample was determined 
based on the standard curve, adjusted for the exposure control samples.  The adduct level was 
then adjusted for the amount of keratin recovered from each tape-strip sample (Kang-Sickel 
et al., 2008). 
3.3.3. Data Analysis 
All statistical analyses were conducted using the SAS software (V.9.1.3, SAS 
Institute, Cary, NC) at a significance level of 0.1.  The amount of each of the four adducts 
measured from each sample was adjusted for the amount of keratin removed from the tape-
strip samples to obtain naphthyl-keratin adduct/keratin ratio (pmole/µg), to account for the 
variability in the keratin amount that may occur in each tape-strip sample.  Natural log-
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transformations were made to the four adduct/keratin ratios, K1 (1NK1 + 2NK1) ratio, K10 
(1NK10 + 2NK10) ratio, and total adduct/keratin ratio, to satisfy normality assumption prior 
to statistical analysis.  The total adduct/keratin ratio was selected for further analysis since it 
represents the sum of all possible naphthyl-keratin adducts formed in the epidermis. 
The USAF personnel were assigned to three a priori determined exposure categories 
(high, medium, or low) (Chao et al., 2005).  The least-square t-tests with Tukey’s adjustment 
was performed to investigate differences in adduct levels between bases, exposure groups, 
task performed, demographic factors such as race, and gender, smoking status, and the use of 
personal protective equipment (e.g., booties, gloves, respirators, cotton overalls).  The 
Pearson’s correlation was used to investigate the effect of the average temperature and 
humidity of the sampling month on the keratin adduct levels between each base. 
3.4. Results 
3.4.1. In vitro Human Epidermis 
The absence of naphthalene toxicity to the reconstructed epidermis under these 
exposure levels and conditions was demonstrated by the similar response of all treatment 
groups in the MTT assay (Figure 3.1).  The MTT assay is based on the ability of a 
mitochondrial dehydrogenase in viable cells to cleave the tetrazolium rings of the pale yellow 
MTT and form a dark blue formazan precipitate, which is largely impermeable to cell 
membranes and thus accumulates within healthy cells.  Lysis and solubilization of the cells 
by the addition of a detergent results in the liberation and solubilization of the crystals.  The 
number of viable cells is directly proportional to the level of the formazan created, which can 
be quantified using a colorimetric assay. This assured the validity of the observed dose 
related mRNA responses to naphthalene-induced metabolism in the absence of toxicity. 
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Figure 3.1. Viability (mitochondrial dehydrogenase activity) of the human reconstructed 
epidermis (untreated, acetone vehicle, or naphthalene exposure) was not 
compromised under these conditions and, thus, may allow observation of normal 
homeostatic responses in response to xenobiotic exposure. 
An increase in relative transcript expression levels of a number of cytochrome P450 
genes (CYP1A1, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, and CYP3A5), 
epoxide hydrolase 1 and 2 (EPHX1, EPHX2), and glutathione S-transferase mu 1 (GSTM1) 
were observed in HS-019 SuperArrays (Figure 3.2).  Acetone is an endogenous substrate for 
CYP2E1, especially under caloric restriction and ketosis, and may work with increased 
naphthalene substrate to saturate phase 1 and phase 2 metabolism enzymes.   These data were 
normalized against the consistently expressed GAPDH transcript, and the vehicle (acetone) 
contribution to induction was deducted, thus demonstrating the dose-response relationship 
induced by exposure to naphthalene alone.  This robust activity suggests that many 
cytochrome P450 genes exist in human epidermis, and can be induced by naphthalene.  
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These results demonstrate the capability of human epidermis to express and induce enzymes 
that metabolize xenobiotics, such as naphthalene.  These genes are, thus, candidates for 
genotyping and phenotyping individuals for susceptibility to naphthalene exposure and 
associated disease.  
 
Figure 3.2. Naphthalene significantly (p  0.05) induced many xenobiotic-metabolizing 
genes in the reconstructed human skin.  Relative gene expression normalized to 
GAPDH and vehicle control (acetone). 
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Immunofluorescence staining for 2NK1 adducts was performed on the cross-section 
of the paraffin-embedded tissue samples from the six treatment groups.  We observed that 
signal intensity of 2NK1 adducts in the keratinocytes increased with naphthalene dose 
(Figure 3.3).  The affinity-purified rabbit anti-2NK1 polyclonal antibody retained a low level 
of cross-reactivity to keratin as observed in the untreated and vehicle (acetone) treated skin, 
but still detected a naphthalene dose-related increase in adduct levels that were in agreement 
with gene induction in SuperArray.  Further, the 2NK1 adduct detection signals concentrated 
in the epidermis, primarily the suprabasal layer.  This observation confirms the metabolizing 
capacity of keratinocytes, the core components of the epidermis, which differentiate and form 
the non-viable stratum corneum, from which the tape-strip samples were obtained. 
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Figure 3.3. A dose-related increase in detectable 2NK1 adduct levels was observed in the 
epidermis, but not in the dermis of reconstructed skin, after three topical 
exposures to naphthalene (every other day). Anti-2NK1-red-orange (Alexa Fluor 
546); nuclear DNA-blue (DAP-1). 
3.4.2. Detection of Naphthyl-Keratin Adducts in the Skin of Occupationally Exposed 
Workers 
Keratin protein quantities in the tape-strip skin samples collected from 105 USAF 
personnel occupationally exposed to JP-8 ranged from 29.6 to 1877.3 µg/ml, with mean and 
standard deviation of 652 ± 382 µg/ml.  The variation in the amount of keratin recovered 
from individual tape-strips may reflect the difference in perspiration and other personal 
2NK1 (red-orange) 
Untreated Vehicle 0.02 nmol 
0.2 nmol 2 nmol 20 nmol 
Epidermis/dermis 
junction 
Nuclear DNA (blue) 
Epidermis 
Dermis 
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factors affecting adhesion and removal of the tape.  Hence, the amount of adducts was 
adjusted for the amount of keratin removed in each tape-strip sample to obtain a normalized 
adduct-keratin ratio. 
The four naphthyl-keratin adducts were detected in the tape-stripped skin samples at 
levels from 0.004 to 6.104 pmole adduct/µg keratin with the highest observed for 2NK10 and 
the lowest for 1NK10; the mean naphthyl-keratin adduct levels were 0.19 ± 0.16 (1NK1), 
0.56 ± 0.32 (1NK10), 0.14 ± 0.12 (2NK1), and 2.11 ± 0.88 (2NK10) pmole adduct/µg keratin 
(Table 3.1).  Significant differences were observed between the mean levels of 1NK1 and 
2NK1 (p = 0.0149), 1NK10 and 2NK10 (p < 0.0001), and the total naphthyl-bound K1 
(1NK1 + 2NK1) and total naphthyl-bound K10 (1NK10 + 2NK10) (p < 0.0001).  The mean 
levels of total 1-naphthyl (1NK1 + 1NK10) were significantly lower than the total 2-naphthyl 
(2NK1 + 2NK10) adduct levels (p < 0.0001). 
Table 3.1. The means and standard deviations for levels of four individual naphthyl-keratin 
adducts (1NK1, 2NK1, 1NK10, 2NK10), total keratin-1 adducts, total keratin-10 
adducts, total 1-naphthyl keratin adducts, and total 2-naphthyl keratin adducts 
(pmole adduct/µg keratin) measured in the epidermis of the US Air Force 
personnel exposed to jet fuel. 
Naphthyl-keratin adducts Mean STD Min Max 
1NK1 0.1857
a
 0.1620 0.0407 1.1732 
2NK1 0.1421 0.1206 0.0063 0.6192 
1NK10 0.5593
b
 0.3171 0.0044 1.5079 
2NK10 2.1083 0.8782 0.9349 6.1039 
Total keratin-1 adducts 
(1NK1 + 2NK1) 
0.3278
c
 0.2211 0.0901 1.4921 
Total keratin-10 adducts 
(1NK10 + 2NK10) 
2.6676 1.0581 1.1726 6.2250 
Total 1-naphthyl keratin adducts 
(1NK1 + 1NK10) 
0.7450
d
 0.3217 0.2746 1.6628 
Total 2-naphthyl keratin adducts 
(2NK1 + 2NK10) 
2.2504 0.9558 0.9894 6.4228 
a
 Significantly different from 2NK1 (p = 0.0149) 
b
 Significantly different from 2NK10 (p < 0.0001) 
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c
 Significantly different from total naphthyl-bound K10 (p < 0.0001) 
d
 Significantly different from total 2-naphthyl keratin adduct levels (p < 0.0001) 
 
 
Table 3.2. The means and standard deviations of the log-transformed total naphthyl-keratin 
adduct levels [ln(pmole adduct/µg keratin)] measured in the epidermis of the US 
Air Force personnel exposed to jet fuel. 
Exposure 
Group 
Base A Base B Base C Base D Base E All Bases 
All 
0.642±0.210
a
 
(n = 30) 
1.021±0.259 
(n = 22) 
1.444±0.367
b
 
(n = 15) 
1.270±0.201
b
 
(n = 22) 
1.019±0.258 
(n = 16) 
1.025±0.377 
(n = 105) 
High 
0.630±0.224
a
 
(n = 22) 
1.082±0.248 
(n = 15) 
1.546±0.364
b
 
(n = 9) 
1.315±0.175
c
 
(n = 16) 
1.157±0.150 
(n = 7) 
1.060±0.400* 
(n = 69) 
Medium 
0.541±0.107 
(n = 4) 
0.884±0.273 
(n = 6) 
1.113±0.319 
(n = 2) 
NA 
0.899±0.359 
(n = 5) 
0.835±0.312 
(n = 17) 
Low 
0.811±0.100
d
 
(n = 4) 
0.930 
(n = 1) 
1.380±0.366 
(n = 4) 
1.153±0.232 
(n = 6) 
0.930±0.196 
(n = 4) 
1.070±0.299 
(n = 19) 
Aircraft 
type 
Single-seat 
training/ 
combat 
Fighter
 
Transport
e 
Transport
e Fighter, 
refueling
  
Fuel 
capacity 
(L) 
6,200 20,000 
26,000-
36,500 
33,700 20,000  
n = Number of subjects 
NA = Not applicable; no workers in this category 
a
 Significantly lower than all the other bases 
b
 Significantly higher than bases A, B, and E 
c
 Significantly higher than bases A and B 
d
 Significantly lower than base C 
e
 Significant difference between transport planes (base C and base D) and fighter jets (base B and 
base E) (p < 0.0001) 
* Significant difference between high- and medium-exposure group (p = 0.069) 
The means and standard deviations of the log-transformed total naphthyl-keratin 
adduct levels were 1.060 ± 0.400, 0.835 ± 0.312, and 1.070 ± 0.299 pmole/µg keratin for 
high-, medium-, and low-exposure groups (as classified by a priori assigned exposure 
category), respectively (Table 3.2).  The adduct levels were significantly different between 
the high- and medium-exposure groups (p = 0.069), but not between the medium- and low-
exposure groups, and between the high- and low-exposure groups.  The low-exposure group 
had the highest adduct levels while the high-exposure group had the second highest levels 
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among the exposure groups.  Upon closer examination, it was discovered that majority of 
workers in the low-exposure group (17 of 19) had participated in tasks such as repairing fuel 
lines, fuel tanks, draining and refueling, and reported contact with jet fuel, even though they 
did not partake in fuel-cell maintenance on the sampling day.  Hence, these workers were 
assigned to low-exposure group in the overall study (Chao et al., 2005).  It is very possible 
that these workers had no or minimal contact with JP-8 on the sampling day, but that they 
had had considerable exposure to JP-8 previously during their daily duties that in turn 
resulted in significant naphthyl-keratin adduct formation in the skin. 
Significant differences in the total adduct levels were observed between the five 
USAF bases, with the highest levels observed at base C and the lowest at base A (Table 3.2).  
These differences are likely the result of the types of aircrafts serviced in each base.  The 
bases with the highest adduct levels (C and D) serviced transport planes.  These aircrafts 
have 26,000–36,500 L fuel tanks and are capable of carrying large cargos.  The base with the 
lowest adduct levels (A) provided support for small fighter jets (fuel tank capacity 6,200 L).  
Bases B and E serviced primarily the F-series fighter jets (fuel tank capacity 20,000 L) and 
the measured adduct levels were significantly lower compared to the bases C and D (p < 
0.0001) and significantly higher when compared to base A (p < 0.0001). 
The type and use of personal protective equipment (PPE) such as gloves, booties, and 
aprons were significant in affecting the adduct levels in all subjects (p = 0.005, 0.016, 0.042, 
respectively; data not shown).  Wearing gloves was found to be associated with lower adduct 
levels, indicating their protection against dermal exposure to JP-8.  However, wearing 
booties or aprons were associated with increased adduct formation in the epidermis.  Because 
both booties and aprons were made of cotton material, the increased level of keratin adducts 
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may have been due to cotton’s inadequacy in protecting skin from JP-8 exposure or, worse, 
cotton fabric may have served as a wicking conductor for dermal absorption of JP-8 (Carlton 
and Smith, 2000). 
No significant difference was found between races, genders, smoking status, and, 
interestingly, between workers with or without skin irritation.  However, slightly higher 
adduct levels were observed in workers who reported skin irritation (3.182 vs. 2.871 pmole 
adduct/µg keratin).  The tasks of replacing foam and pumping contaminated air out of the 
tank instead of pumping fresh air into fuel tank were also associated with increased adduct 
levels (p = 0.006 and p = 0.001, respectively). 
In addition to the types of aircrafts serviced in these bases, the differences in adduct 
levels may also be influenced by the temperatures and humidity of the geographical locations 
of the bases, as well as differences in the maintenance practices, personal hygiene, and the 
type and use of PPE.  The results showed that the adduct levels strongly correlated with the 
average low temperature of the sampling month (r = 0.908, p = 0.033) and moderately with 
average high temperature of the sampling month (r = 0.826, p = 0.085) (data not shown). 
3.5. Discussion 
The data obtained from the in vitro reconstructed human epidermis confirm the 
existence and dose related induction of both phase I and phase II xenobiotic-metabolizing 
enzymes (Figure 3.2), including CYP2E1, in the human epidermis as reported previously 
(Pavek and Dvorak, 2008).  CYP families 1, 2, and 3 are major xenobiotic-metabolizing 
enzymes in humans (Nelson, 2002), and CYP1A1, 1B1, 2B6, 2E1, and 3A are expressed 
significantly greater in normal human skin keratinocytes relative to fibroblasts (Baron et al., 
2001).  This corroborates our new findings of the dose-responsive induction of CYP2E1, 
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involved in naphthalene metabolism, along with several other xenobiotic-metabolizing 
enzymes (Figure 3.2), and 2NK1-adduct formation that occurred in the viable reconstructed 
epidermis (Figure 3.3), but not the dermis.  Naphthalene undergoes oxidative metabolism by 
cytochrome P450 enzymes resulting in the production of reactive epoxides (Jerina et al., 
1970; Wilson et al., 1996).  These epoxides react with sulfhydryl group of the cysteine 
residue in the exposed head region of K1 or K10, forming naphthyl-keratin adducts, as we 
observed in the USAF personnel; or they may react with other cellular components, such as 
membrane lipids and DNA inducing adducts and mutations, increasing the risk for cancer. 
The total naphthyl-K1 levels observed were significantly lower than the total 
naphthyl-K10 (p < 0.0001).  These results confirmed our previously reported observation 
using samples collected from 13 individuals occupationally exposed to jet fuel (Kang-Sickel 
et al., 2008).  K1 and K10 are normally present in 1:1 ratio in healthy human skin and form 
the intermediate filaments, which provide structure and strength to the squame.  However, 
K10 up-regulation and K1 down-regulation in keratinocyte cell cultures exposed to JP-8 has 
been reported (Witzmann et al., 2005).  In addition, inter-individual differences in 
xenobiotic-metabolizing enzyme function due to non-synonymous SNPs and structural 
variants may affect metabolic activity and an individual’s ability and efficiency to form 
reactive metabolites.  Individual differences in detoxification capacity may alter 
susceptibility to exposure related disease (Alexandrie et al., 2000).  Associations between 
diseases, such as cancer, and genetic polymorphisms (SNPs and copy number variants) of 
xenobiotic-metabolizing enzymes, such as cytochrome P450s and GSTs, have been reported 
(Figueroa et al., 2008; Majumdar et al., 2008; Torresan et al., 2008).  More studies are 
needed to elucidate the relationship between individual genetic polymorphisms and their 
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effects on exposure biomarkers and disease risk.  Further, more research is required to 
understand naphthyl-keratin adducts and urinary naphthol levels, and the implications for an 
individual’s long-term disease susceptibility to naphthalene exposure. 
The significant differences in adduct levels between the five USAF bases are 
particularly interesting.  Some workers routinely enter the wing tanks of transport planes 
(bases C and D), providing a significant potential for dermal contact with jet fuel, while the 
wing tanks of some fighter jets are too small for entry, which may reduce workers’ potential 
for exposure.  In addition, significantly higher adduct levels were observed in workers 
participating in tasks involving foam replacement and ventilation.  Similarly, Carlton and 
Smith (2000) observed significantly higher air concentrations of benzene in workers involved 
in foam procedures compared to other tasks.  These workers were likely exposed to the 
residual fuel in the wet foams during routine maintenance.  The hydrophilic property of 
polyurethane foam, may allow aromatic hydrocarbons, such as naphthalene, to be absorbed 
into the foam compared to that of the alkane hydrocarbons, which are less hydrophilic.  
Therefore, the foam may absorb more aromatic hydrocarbons from the fuel and, thus, 
increasing the exposure potential during foam handling. 
This research supports the use of naphthyl-keratin adducts as biomarkers of exposure 
when assessing dermal exposure to naphthalene, as a marker for jet fuel exposure, based on 
the dose-related enzyme expression and adduct formation observed both in vitro and in vivo.  
These data also confirm our approach to use non-invasive sampling of skin by tape stripping 
and ELISA analysis of epitope-specific antigens to determine prior and cumulative chronic 
exposure to naphthalene, as a marker for JP-8 exposure.  By studying the adduction of 
keratin occurring in the viable epidermis and subsequently in the stratum corneum available 
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for noninvasive sampling, we were able to investigate both external and internal factors 
contributing to keratin protein adduction during dermal exposure, including exposure levels, 
tasks performed, and use of PPE.  Further, our study exemplifies the inherent problem of 
exposure misclassification in epidemiology studies that rely on a priori determined job 
groups without the knowledge of quantitative exposure or biomarker of exposure data. 
Quantification of dermal exposure is especially relevant for the USAF personnel who 
enter fuel tanks to perform maintenance tasks and whose dermal protection is insufficient 
with cotton overalls.  Urinary naphthols have been suggested as sensitive biomarkers for 
exposure to ambient PAH in the general population (Yang et al., 1999; Serdar et al., 2004).  
However, no consideration was made to quantify dermal exposures to PAHs in these studies.  
We observed in our previous studies that dermal exposure, along with inhalation exposure, is 
an important route for jet fuel exposure and that dermal exposure can contribute significantly 
to the total body burden (Chao et al., 2005; Chao et al., 2006; Kim et al., 2007).  Future 
studies are warranted to examine the relationship between keratin adducts and urinary 
naphthols as informative biomarkers of systemic exposure, and their relationship in regard to 
acute and chronic exposure to jet fuel and to validate the use of keratin adducts as biomarkers 
of jet fuel exposure.  The relationship between individual differences in metabolic capacity 
and levels of these biomarkers should also be taken into account.  Accurate estimation of the 
contribution of dermal exposure to the systemic dose is required in order to complement and 
improve current exposure and risk assessment models for long-term health effects of jet fuel 
(naphthalene) exposure, a facet that is missing from current epidemiological research. 
In summary, we have demonstrated ability of the human epidermis to metabolize 
naphthalene and to form naphthyl-keratin adducts both in vitro and in vivo.  We also 
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demonstrated the feasibility of utilizing ELISA to quantitate specific naphthyl-keratin 
adducts from the tape-striped samples collected from the skin of workers routinely exposed 
jet fuel.  The ability to quantitate keratin adducts as biomarkers of dermal exposure will 
enable us to distinguish systemic dose resulting from dermal exposure from other routes of 
exposure.  Since determination of exposure biomarkers from all sources of exposure contact 
is critical to understanding systemic exposure and toxicity, the techniques described in this 
study will allow us to better estimate total systemic dose for inclusion in exposure- and risk-
assessment models, and possibly to illustrate the mechanisms of the xenobiotics-
metabolizing pathways.
 
 
Chapter 4 
4. The Utility of Naphthyl-Keratin Adducts as Biomarkers for Jet-Fuel Exposure 
Juei-Chuan C. Kang-Sickel, Mary Ann Butler, Lynn Frame, Christine A. Toennis, Yi-Chun E. 
Chao, Stephen M. Rappaport, Berrin Serdar, Peter Egeghy, John E. French, and Leena A. 
Nylander-French (manuscript) 
4.1. Abstract 
Dermal exposure to naphthalene, as a marker of jet fuel exposure, has been observed 
to contribute significantly to the total body burden of naphthalene in fuel-cell maintenance 
personnel.  We investigated factors influencing dermal exposure to naphthalene in 105 fuel-
cell maintenance workers who were routinely exposed to naphthalene-containing jet-fuel (JP-
8), using novel skin keratin adducts as biomarkers of exposure.  We examined the correlation 
between total naphthyl-keratin adduct (TNKA) levels and exposure measures including 
dermal, end-exhaled breath, and breathing-zone naphthalene levels as well as various 
naphthalene biomarker levels in urine.  A moderate correlation was observed between TNKA 
and urine naphthalene levels (r = 0.1841, p = 0.0614).  Multivariate linear regression 
analyses showed that TNKA level was influenced by dermal naphthalene level, exposure 
time, and worker’s age (for all p < 0.0001).  In addition, TNKA level, post-exposure breath 
naphthalene level, GSTT-plus (++/+-) and CYP2E1*6 wild-type (DD) genotypes, as well as 
worker’s gender were observed to significantly influence urine naphthalene levels (for all p < 
0.0001).  In conclusion, TNKAs show great promise as biomarkers for dermal exposure to 
naphthalene.  Further studies are warranted to characterize the relationship between naphthyl-
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keratin adducts, other biomarkers and/or biomarkers of effect, and JP-8 health effects, in 
order to validate their utility as biomarkers of naphthalene and/or PAH exposure. 
4. 2. Introduction 
Accurate quantification of the contribution of dermal exposure to the systemic dose is 
required in order to complement and improve current exposure assessment models for long-
term health effects of jet fuel exposure, a facet that is missing from current epidemiological 
research.  Quantitation of the individual dermal dose and determination of the mechanism of 
action hinges upon development of biomarkers that can encompass both acute and chronic 
exposure and upon development of specific analytical procedures to quantitate these 
biomarkers.  The only method for quantitation of dermal dose of jet fuel reported to date 
detects the unchanged naphthalene (parent compound) on the surface of the skin, which can 
be attributed to recent exposure only (Chao et al., 2005; Chao et al., 2006).  Adducts bound 
to keratin would be an appropriate and specific biomarker for chronic exposure, as the 
bioactivation required to generate adducts from naphthalene occurs only in the suprabasal 
layer of the epidermis, where keratin is synthesized de novo (Watt, 1988a).  Approximately 
28 days are required for differentiation and maturation of suprabasal keratinocytes (Junqueira 
and Carneiro, 2005; Furukawa et al., 2008) to migrate from the basal layer to form the 
stratum corneum.  Thus, periodic non-invasive sampling by tape stripping can be used to 
determine prior and cumulative chronic exposure and to provide some measure of individual 
variation in metabolic capacity. 
The potential contribution of JP-8 dermal exposure to increased urine biomarker 
levels (e.g., 1- and 2-naphthol) was implied based on their correlation to surrogate factors 
used as indicators of dermal exposure (e.g., skin irritation, work inside the fuel cell, cleaning 
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fuel puddles) (Egeghy et al., 2003; Serdar et al., 2004).  We have previously established that 
naphthalene (as a model polycyclic aromatic hydrocarbon) and its metabolites 1-naphthol (1-
NAP) and 2-naphthol (2-NAP) in urine can be used as quantitative biomarkers of a complex 
fuel mixture exposure to the skin (Chao et al., 2006).  We further established that dermal 
exposure, along with inhalation exposure, to jet fuel was observed to contribute significantly 
to the total body burden in the US Air Force (USAF) fuel-cell maintenance workers (Chao et 
al., 2005; Kim et al., 2007).  We have also shown that highly specific polyclonal antibodies 
of naphthalene metabolites can be used for a sensitive enzyme-linked immunosorbent assay 
(ELISA) for quantification of naphthyl-keratin adducts as biomarkers of dermal exposure to 
jet fuel (Kang-Sickel et al., 2008).  In dermal tape-strip samples collected from 105 
individuals exposed to JP-8, naphthyl-conjugated peptides were detected at levels from 0.004 
to 6.104 pmol adduct/µg keratin, but were undetectable in unexposed volunteers (Kang-
Sickel et al., 2008). 
The objective of this study was to investigate the association between biomarkers of 
dermal exposure and naphthalene and its metabolite levels in 105 fuel cell maintenance 
workers along with inhalation exposure, individual and work place factors that may 
contribute to these levels using multivariate linear regression models.  Polycyclic aromatic 
hydrocarbons (PAHs), such as naphthalene, require metabolic activation and subsequent 
binding to a nucleophilic macromolecule (protein or DNA) to form adducts.  Therefore, we 
also examined the potential contribution of genetic variants in four metabolic genes 
(CYP2E1, GSTT1, GSTM1, NQO1), intrinsic to naphthalene metabolism, in the observed 
levels of naphthyl-keratin adducts and urine naphthyl biomarkers in this worker population. 
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Figure 4.1. Propose Naphthalene metabolism in human [adapted from Waidyanatha et al. 
(2004)]. 
4.3. Materials and Methods 
4.3.1. Study Population 
The study population consisted of 105 fuel-cell maintenance workers exposed to jet 
fuel (JP-8) at five USAF bases in the continental US [described in Chao et al. (2006)].  
Workers were recruited with informed consent from active duty USAF personnel who 
routinely worked with and were exposed to JP-8.  This study was approved by the 
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institutional review board for each of the participating investigators and for the USAF, and 
the study complied with all applicable U.S. requirements and regulations. 
Questionnaires and work diaries were recorded after the work shift to obtain detailed 
information on demographic factors including age, ethnicity, gender, smoking status, job 
tasks and durations, use of personal protective equipment (PPE), and other work-related 
characteristics.  Each of the workers had been assigned a priori into one of three exposure 
categories (high, moderate, low) based on the primary career field (TTU, 2001).  Fuel-cell 
maintenance workers were assigned to the high-exposure category.  Subjects with regular 
contact with jet fuel via fuel handling, distribution, recovery, and testing were assigned to the 
moderate exposure category.  Subjects without contact to JP-8, such as military police, were 
assigned to the low-exposure category. 
4.3.2. Collection and Analyses for Skin, Inhalation, and Urine Samples 
The collection of dermal tape-strip samples and analysis for naphthalene (Chao et al., 
2005) and naphthyl-keratin adduct (NKA) levels (Kang-Sickel et al., 2008) has been 
described previously.  Briefly, tape-strip samples were collected post-exposure using three 
sequential adhesive tape-strips in each site (2.5 cm  4.0 cm, surface area 10 cm2; Cover-
Roll
TM
 tape, Beiersdorf AG, Germany) from three body regions with potentially the greatest 
JP-8 exposure.  In each site, side-by-side samples were collected, one set for determination of 
naphthalene level and the other set for determination of NKA level.  Each tape was applied 
onto the skin surface with a constant pressure and removed at an approximately 45-degree 
angle after one minute.  For determination of naphthalene level, tape was folded and placed 
into a labeled scintillation vial containing 5 ml acetone and 20 µl of 25 µg/ml naphthalene-d8 
(internal standard) and stored at –80C until analysis by gas chromatography-mass 
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spectrometry (GC-MS).  For determination of NKAs, tape was rolled with the adhesive side 
facing out and placed into a 2-ml cryovial and stored at –80C until the keratin from the 
epidermis sampled was extracted and quantified by Bradford assay and NKAs quantified by 
ELISA (Kang-Sickel et al., 2008). 
Inhalation exposure to naphthalene was monitored during the 4-h work shift using 
passive monitors attached to the workers’ collars.  End-exhaled breath samples were 
collected before and immediately after the work shift using 75-cm
3
 glass bulbs.  A full-face 
supplied-air respirator was worn by 69 (100%) of the a priori high-exposure group workers, 
while 10 (59%) of medium exposure and none of the low exposure workers wore a respirator.  
Both breathing-zone air and breath samples were analyzed by thermal desorption followed by 
GC-MS with photo-ionization detection, as described elsewhere (Egeghy et al., 2003).  The 
collection of urine samples was performed before and after the work shift and the 
concentrations of the urine 1- and 2-NAP were determined by GC-MS, as described 
elsewhere (Serdar et al., 2003). 
4.3.3. Genotyping for Candidate Genes 
One whole blood sample was collected into a 10 ml EDTA vacutainer tube from each 
worker at the beginning and at the end of the work shift and was shipped on Blue Ice

 
(Rubbermaid, Atlanta, GA) to maintain a temperature of 4°C to arrive within 24 hours.  The 
genomic DNA for GSTM1 genotyping was isolated from 0.4 ml of whole blood using 
InstaGene Genomic DNA Kit (Cat #732-6028, BioRad, Hercules, CA) while DNA for 
CYP2E1, GSTT1, and NQO1 genotyping was isolated from 0.3 ml of whole blood using 
Gentra Puregene Blood Kit (Qiagen Sciences, Inc., Germantown, MD) following procedures 
provided by the manufacturers.  GSTM1 and GSTT1 genotypes were identified using primers 
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described by Hirvonen et al. (1996).  The PCR reaction mixture contained 1X Applied 
Biosystems PCR Buffer II, 2 mM MgCl2, 2.5 pmol of each dNTP primer, 30 pmol of each 
GSTM1 and GSTT1 primer, 10 pmol of each -globin primer, 1 unit AmpliTaq Gold 
Polymerase, and 2 µl of DNA extract.  The reaction mixture was placed in a thermocycler 
(model PTC-100, MJ Research Inc., Waltham, MA) for 10 min at 95°C followed by 25 
cycles of 94°C for 1 min, 59°C for 1 min, 72°C for 1.5 min, and a final step of 72°C for 5 
min.  GSTM1-null and GSTT1 individuals were identified by DNA templates that produced 
no amplification with GSTM1 and with GSTT1 specific primers.  The CYP2E1Dra1 (mutant 
allele: CYP2E*6) restriction fragment length polymorphism (RFLP) was identified by minor 
modifications of methods described by Kato et al. (1995).  CYP2E1 has a polymorphic DraI 
restriction site in intron six.  The DraI restriction site is present in the CYP2E1 DraI Type D 
genotype, whereas the site is missing in the CYP2E1 DraI Type C genotype.  GSTT1 
genotypes were identified based on the methods described in Pemble et al. (1994).  Minor 
modifications of the methods described by Wiemels et al. (1999) were used to characterize 
the single nucleotide polymorphisms rs1800566 in NQO1.  This genetic variant has a C to T 
transition in nucleotide 609 in exon 6 of NQO1 (Guha et al., 2008).  Minor modifications of 
the CYP2E1 and NQO1 methods included substituting Ampli Taq Gold Polymerase for 
AmpliTaq Polymerase, using Applied Biosystems PCR Buffer II in the reaction mixtures, 
and including a 10 min preincubation of the reaction mixtures at 95°C prior to beginning the 
specified amplification programs.  In addition, amplification and restriction products were 
examined on 2 percent agarose E-gels (Invitrogen Life Technologies, Carlsbad, CA) or 2 
percent agarose gels prepared in the laboratory.  Duplicate reactions were conducted on a 
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minimum of 40 percent of the participants and all duplicate results were in complete 
concordance (Hirvonen et al., 1996). 
4.3.4. Statistical Analyses 
All statistical analyses were conducted using the SAS software (V.9.1.3, SAS 
Institute, Cary, NC, USA) at a significance level of 0.10.  All exposure and biomarker data 
(NKA levels, dermal, breathing-zone air, and breath naphthalene levels, as well as urine 
naphthalene and naphthol levels) were natural log-transformed to satisfy normality 
assumptions prior to statistical analysis. 
Pearson correlation was examined between the total naphthyl-keratin adduct (TNKA) 
level and JP-8 exposure measures (i.e., dermal, breathing-zone, pre- and post-exposure breath 
naphthalene levels) and urine biomarkers [i.e., naphthalene, 1-NAP, 2-NAP, and total 
naphthol (TNAP = 1-NAP + 2-NAP) levels].  The least-square t-tests were performed to 
investigate effects of genetic variants in four metabolic genes (CYP2E1, GSTT1, GSTM1, 
NQO1), which have been indicated in naphthalene metabolism (Tingle et al., 1993; Wilson et 
al., 1996; Yang et al., 1999; Lee et al., 2001), on the observed levels of TNKAs and urine 
biomarkers in this worker population. 
Multivariate linear-regression analyses were conducted to examine workplace and 
personal factors contributing to TNKA levels upon jet fuel exposure.  Stepwise variable 
selection was used to determine final regression models, with α = 0.10 as the inclusion level 
for predictors.  The basic multivariate linear regression model was as follows: 
 
 
Yi     jX i j  kCi k
k1
K
  i
j1
J
  (1) 
Where, Yi is the natural log-transformed TNKA-keratin ratio measured in the ith worker’s 
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tape-strip samples,  is the intercept, Xij represents the ith worker’s jth dermal naphthalene 
level, Cik represents the kth covariate value for the ith worker based on work diary and 
questionnaire, including exposure time, job task, PPE, age, gender, and smoking status, as 
well as metabolic genotypes CYP2E1, GSTM1, GSTT1, and NQO1. 
A second multivariate linear regression analysis was used to investigate the 
relationship between the urine biomarkers and the TNKA levels as well as the contribution of 
the covariates also analyzed in model 1.  The basic multivariate linear regression model was 
as follows: 
 
 
Yi     jX i j  kCi k
k1
K
  i
j1
J
  (2) 
where, Yi is the natural log-transformed urine biomarker level, measured in the ith worker’s 
urine samples;  is the intercept; Xij represents the ith worker’s jth TNKA level; Cik 
represents the kth covariate value for the ith worker, which included exposure data, PPE 
usage, metabolic genotypes CYP2E1, GSTM1, GSTT1, and NQO1, age, ethnicity, gender, 
and smoking status.  Collinearity was examined for all models using variance inflation, 
condition indices, and eigenvalues.  Possible outliers were examined by studentized 
residuals. 
4.4. Results 
No significant correlation was observed between the TNKA levels and exposure measures 
(i.e., dermal, breath, and breathing-zone naphthalene levels) nor the urine 1-NAP, 2-NAP, or 
TNAP levels with the exception of urine naphthalene level (Pearson correlation r = 0.1841, p 
= 0.061) (Table 4.1). 
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The association between biomarker levels (i.e., TNKA level and urine 1-NAP, 2-
NAP, TNAP, or naphthalene level) and the genotype of each of the four genes (GSTM1, 
GSTT1, NQO1, and CYP2E1) are presented in Table 4.2.  A significant difference in TNKA 
level was observed between individuals with GSTT-null genotype and those with at least one 
copy of GSTT gene (p = 0.0802).  Individuals carrying NQO1 homozygous variant (TT) also 
had significant lower levels of keratin adduct level than those with homozygous wildtype 
(CC) (p = 0.0847). 
Table 4.1. Pearson correlation coefficients (r) between the total skin naphthyl-keratin adduct 
levels [ln(ng adduct/µg keratin)] and the exposure and biomarker levels observed 
in the U.S. Air Force personnel exposed to jet fuel. 
Exposure or Biomarker n Pearson Correlation (r) p-value 
Dermal naphthalene (ng/m
2
) 105 -0.038 0.704 
Pre-exposure breath naphthalene 
[ln(ng/m
3
)] 
103 0.149 0.133 
Post-exposure breath naphthalene (ng/m
3
) 101 0.038 0.707 
Breathing-zone naphthalene [ln(ng/m
3
)] 100 0.043 0.668 
Urine 1-naphthol [ln(µg/l)] 104 0.080 0.418 
Urine 2-naphthol [ln(µg/l)] 104 0.012 0.907 
Total urine naphthols [ln(µg/l)] 104 0.033 0.740 
Urine naphthalene [ln(µg/l)] 104 0.184 0.061 
n = number of workers 
The regression analysis showed that TNKA level was influenced by dermal 
naphthalene level (lndermal), duration of exposure on the sampling day (exposure time), and 
age (Table 4.3).  The dermal naphthalene level and the age of the worker were inversely 
associated with TNKA level while exposure time increased TNKA levels.  When we 
investigated the factors related to workers assigned into the a priori high-exposure group 
only (n = 68), these same three predictors as for all workers were observed to be significant 
(Table 4.3).  None of the four metabolic genotypes was observed to be significantly 
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associated with TNKA level in either multivariate linear-regression model when other 
significant covariates were included in the models. 
 
  
6
2
 
 
Table 4.2. The averages, standard deviations, and ranges of the total skin naphthyl-keratin adduct (TNKA) level [ln(ng/µg 
keratin)] and urine biomarker levels [ln(µg/l)] as well as the associations between these biomarker levels and the 
specific genotypes in the U.S. Air Force personnel exposed to jet fuel. 
 Prevalence (%) TNKA 1-Naphthol 2-Naphthol Total Naphthols Naphthalene Total Urine Biomarkers* 
Average  1.03 9.58 9.96 10.54 5.40 10.56 
STD  0.38 1.19 1.17 1.13 2.21 1.14 
Range  0.24 – 2.04 6.18 – 11.31 6.18 – 12.49 6.88 – 12.53 -0.84 – 10.59 6.89 – 12.53 
        
Association:        
GSTM1 null 63/105 (40) 1.03 9.52 9.94 10.50 5.13 10.52 
GSTM1 plus 42/105 (60) 1.03 9.68 10.00 10.60 5.82 10.64 
GSTT1 null 24/105 (23) 0.91
a
 9.81 9.99 10.64 5.88 10.65 
GSTT1 plus 81/105 (77) 1.06 9.51 9.96 10.51 5.26 10.54 
NQO1        
CC 66/105 (63) 1.06 9.75 10.08 10.69 5.60 10.71 
CT 34/105 (32) 1.00 9.25 9.75 10.26 4.87 10.28 
TT 5/105 (5) 0.69
b
 9.68 9.97 10.56 6.43 10.578 
CYP2E1        
DD 88/105 (84) 1.04 9.55 9.94 10.52 5.29 10.55 
CD 14/105 (13) 0.91 9.78 10.07 10.65 6.13 10.67 
CC 3/105 (3) 1.18 9.63 10.03 10.54 5.26 10.56 
* The sum of 1-naphthol, 2-naphthol, and naphthalene levels.
 
a
 Significant difference (p = 0.0802) from the mean level in the GSTT1 plus group.
 
b
 Significant difference (p = 0.0847) from the mean level in the NQO1 (CC) type. 
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Table 4.3. Regression analyses for the total skin naphthyl-keratin adduct levels [ln(ng 
adduct/µg keratin)] in the U.S. Air Force personnel exposed to jet fuel. 
Workers n R
2
 Predictor 
Parameter 
Estimate 
Standard 
Error 
p-value
a
 
All 103 0.267 intercept 0.746 0.239 0.0024 
   lndermal
b 
-0.038 0.015 0.0161 
   exposure time 0.004 0.001 <0.0001 
   age -0.019 0.006 0.0032 
High-exposure 
group 
68 0.326 intercept 0.873 0.298 0.0047 
   lndermal
b 
-0.047 0.019 0.0167 
   exposure time 0.004 0.001 <0.0001 
   age -0.022 0.009 0.0214 
n = number of workers 
a
 Stepwise regression variable inclusion and elimination decisions conducted at the -level 
0.10. 
b
 Log-transformed dermal naphthalene level [ln(ng/m
3
)]. 
Based on the Pearson correlation results (Table 4.1), a second regression model was 
constructed using urine naphthalene as the outcome variable.  The significant predictors for 
urine naphthalene levels were TNKA level, post-exposure breath naphthalene level (lnpost-
breath), presence of one or two copies of GSTT1 gene (++/+-), CYP2E1*6 DD (wild type) 
genotype, and gender (Table 4.4).  The TNKA level, post-exposure breath naphthalene level, 
and gender were associated with a increase in the urine naphthalene level while the presence 
of one or both copies of GSTT1 gene and CYP2E1*6 DD genotype were associated with a 
decrease in naphthalene level.  When this analysis was limited to the workers in the a priori 
high-exposure group (n = 64), 24.5% of the total variance in the urine naphthalene level was 
explained by the TNKA and post-exposure breath naphthalene levels as well as GSTT1 
genotype. 
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Table 4.4. Regression analyses for the urine naphthalene levels [ln(µg/l)] in the U.S. Air 
Force personnel exposed to jet fuel. 
Workers n R
2
 Predictor 
Parameter 
Estimate 
Standard 
Error 
p-value
a
 
All 96 0.351 intercept -1.606 1.310 0.2234 
   naphthyl-keratin adducts
b
 0.826 0.418 0.0510 
   lnpost-breath
c
 0.870 0.149 <0.0001 
   GSTT1 (++/+-) -0.912 0.387 0.0207 
   CYP2E1 (DD) -1.102 0.417 0.0097 
   Gender 1.505 0.564 0.0091 
High-exposure 64 0.245 intercept 0.358 1.546 0.8178 
group   naphthyl-keratin adducts
b
 0.951 0.452 0.0396 
   lnpost-breath
c
 0.716 0.182 0.0002 
   GSTT1 (++/+-) -0.940 0.433 0.0339 
n = number of workers 
a
 Stepwise regression variable inclusion and elimination decisions conducted at the -level 
0.10. 
b
 Log-transformed total naphthyl-keratin adduct levels [ln(ng adduct/µg keratin)]. 
c
 Log-transformed post-exposure breath naphthalene level [ln(µg/m
3
)]. 
4.5. Discussion 
Previously, we demonstrated the human skin’s capacity to express enzymes for 
xenobiotic metabolism and to form naphthyl-keratin adducts in response to naphthalene 
exposure (Kang-Sickel et al., 2008).  We also demonstrated that these adducts can be 
quantitatively measured in the exposed skin of workers, which will facilitate investigation of 
naphthalene exposure assessment, particularly regarding the dermal route (Kang-Sickel et al., 
2008; Kang-Sickel et al., 2010).  In addition, inhalation and dermal exposure were identified 
as significant factors contributing to the total systemic dose of naphthalene, measured as 
urine naphthol levels, in workers exposed to jet fuel (Serdar et al., 2004; Chao et al., 2006; 
Kim et al., 2007).  Similarly, urine naphthalene was identified as a biomarker for both dermal 
and inhalation exposure to PAHs (Campo et al.; Sobus et al., 2009a; Sobus et al., 2009b). 
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In this study, we examined the relationship between the skin TNKA levels and 
biomarkers of naphthalene exposure, as a surrogate for JP-8 exposure.  We did not observer a 
significant correlation between TNKA levels and breath naphthalene or urine naphthol levels.  
However, we did observe a significant correlation between TNKA and urine naphthalene 
levels (r = 0.184, p = 0.061).  These results suggest that the level of dermal exposure 
exceeded metabolic capacity in the skin and, therefore, the association was greater with the 
parent compound in urine than with the naphthols.  In addition, inhalation exposure to PAHs 
has been identified as the source of urine naphthol levels (Yang et al., 1999; Kim et al., 
2001).  Since 75% of the study population (79/105) wore full-face supplied-air respirators, 
inhalation exposure to jet fuel was greatly reduced while the contribution of dermal exposure 
to the systemic exposure was increased and, thus, resulting in the lack of association between 
the skin NKA levels and the breath naphthalene or urine naphthol levels.  However, this 
association may also be, in part, due to the differences in the biological half-lives.  The half-
life of naphthalene in breath is estimated to be 22 min (Egeghy et al., 2003), while half-lives 
for urine naphthols are 1.2 – 4.6 h in a rapid phase, and 14 – 46 h in a slow phase (Bieniek, 
1994; Heikkila et al., 1995).  The NKA in the skin are formed via dermal metabolism and 
manifested after the processes of keratinocytes maturation, proliferation, differentiation, and 
migration to the surface of stratum corneum, which take approximately 28 days (Junqueira 
and Carneiro, 2005; Furukawa et al., 2008).  The lack of correlation between various urine 
biomarkers and protein adduct levels has been observed in several studies in regard to PAH 
exposure.  Omland et al. (1994) observed no correlation between any of the PAH exposure 
variables, such as PAH particulates, total PAHs, or benzo(a)pyrene-albumin adduct levels.  
No relationship was found between the albumin adducts and 1-hydroxypyrene, a 
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conventional urine biomarker for PAH exposure, in paving workers (Jongeneelen et al., 
1986), coke oven workers (Jongeneelen et al., 1990), or foundry workers (Sherson et al., 
1992). 
Using multivariate linear regression models in order to consider both environmental 
and genetic factors, we observed that the TNKA levels measured in the skin of fuel-cell 
maintenance workers were positively associated with exposure time but inversely associated 
with the measured dermal naphthalene level and age.  Interestingly, we observed previously 
that exposure time was associated with lower dermal naphthalene level (Chao et al., 2005).  
Exposure time was defined as the time between starting work and dermal sampling.  Due to 
the lag-time between exposure and dermal sampling as well as the relatively fast dermal 
penetration rate of naphthalene, more naphthalene was absorbed into the stratum corneum as 
exposure time increased and metabolized by keratinocytes and to form keratin adducts.  
Thus, less naphthalene was available on the surface of the stratum corneum available for 
tape-strip sampling.  However, once the amount of naphthalene absorbed exceeded the 
epidermal metabolic capacity, the dermal naphthalene levels potentially continued to increase 
while the TNKA levels remained unchanged due to metabolic saturation.  Thus, an inverse 
relationship between TNKA and dermal naphthalene levels was observed. 
Based on the coefficients of the TNKA level on age (-0.019 for all workers and -
0.022 for high-exposed group; Table 4.3), the data suggest an approximate 2% reduction of 
naphthalene metabolisms with each year of age increase in this subject population.  This 
finding is consistent with a 3% reduction in naphthoquinone-albumin adduct level, and 2% 
reduction in 1,4-benzoquinone-albumin adduct level per year of increase in workers exposed 
to PAHs (Rappaport et al., 2002; Waidyanatha et al., 2004).  Experimental evidence also 
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suggests that percutaneous absorption of some chemicals decrease with increasing age 
(Christophers and Kligman, 1965; Tagami, 1972; Roskos et al., 1989).  This change may be 
due to the lesser water and lipid contents in the aged skin compared to young skin, which 
may affect the skin permeability (Blank and McAuliffe, 1985) and exogenous chemicals 
partitioning into the stratum corneum. 
Since naphthalene requires metabolic activation in order to create an electrophilic 
intermediate to react with a nucleophilic amino acid in protein, we examined the effects of 
four metabolic genotypes (CYP2E1, GSTM1, GSTT1, and NQO1) on the measured TNKA 
levels in the skin and on the urine biomarker levels using least-square t-test (Table 4.2).  We 
also examined the effects of these genotypes on the TNKA (Table 4.3) and the urine 
naphthalene levels (Table 4) using linear regression modeling by considering personal and 
environmental factors.  These results showed that individuals with GSTT1-plus (++/+-) 
genotype had significantly higher TNKA levels than the GSTT-null individuals (Table 2).  
However, the effects of GSTT1 became insignificant in regard to TNKA levels once other 
personal and environmental factors were considered in the linear regression model (Table 
4.3).  Interestingly, GSTT1-plus (++/+-) genotype was negatively associated with the urine 
naphthalene levels in the linear regression model (Table 4.4).  The effect sizes of the personal 
and environmental factors, such as exposure duration and dermal naphthalene level, may 
outweigh the effect associated with these metabolic genotypes.  Our results and the 
conflicting research data in the current literature indicate the lack of understanding of the 
involvement of GSTT1 in naphthalene metabolism and the complexity of investigating 
individual susceptibility factors in the context of environmental/occupational exposure.  No 
significant association between GSTT1 genotype and naphthalene metabolism has been 
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observed (Lee et al., 2001; Nan et al., 2001).  In other reports, individuals with GSTT-null 
genotype have been observed to have higher risk for benzene toxicity (Wan et al., 2002) and 
bladder cancer (Hung et al., 2004).  On the contrary, Garte et al. (2007) observed a protective 
effect due to GSTT-null genotype in regard to DNA damage. 
The second multivariate linear regression models showed that urine naphthalene level 
increased as the TNKA and post-exposure breath naphthalene levels increased (Table 4.4).  It 
is likely that increases in these biomarker levels point to significant exposure to jet fuel and, 
in turn, gradual saturation of the body’s metabolic capacity and observed increased 
naphthalene level in urine.  The induction of CYP2E1 is known to increase the formation of 
naphthols from naphthalene, and the polymorphisms in this gene are associated with urine 2-
NAP levels in Korean coke oven workers, who were exposed to PAHs via both inhalation 
and dermal routes (Wilson et al., 1996; Nan et al., 2001).  Therefore, the inverse association 
between CYP2E1*6 wild-type (DD) and the urine naphthalene levels was expected.  
Interestingly, the same association was not observed in the model constructed with a priori 
high-exposure group.  It is possible that in the high-exposure group, the naphthalene-to-
naphthol pathway had been saturated, leading to constant naphthol levels, which prevented 
observation of a significant effect with CYP2E1 genotypes in this subject population. 
In conclusion, this is the first comprehensive study investigating the contribution of 
both environmental and genetic factors in regard to the formation of skin keratin adducts and 
the relationships between TNKA levels and other JP-8 exposure biomarkers in 
occupationally exposed workers.  Quantitation of naphthyl-keratin protein adducts in the skin 
of jet fuel exposed individuals allows us to investigate the importance of dermal exposure, 
penetration, metabolism, and adduction of naphthalene and to predict more accurately the 
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contribution of dermal exposure to systemic dose for use in exposure assessment models.  
The TNKA levels were affected by the work scenarios and personal factors, and were 
associated with the urine naphthalene levels, indicating their potential as quantitative 
biomarkers of dermal exposure.  In addition, this novel biomarker of dermal exposure may 
also be utilized in exposure assessment for other common PAHs and environmental 
pollutants.  Further studies are needed in regard to the relationship between skin NKAs, 
biological effect markers, and JP-8 health effects to further explore the potential application 
of these adducts as biomarkers of naphthalene exposure.
 
 
Chapter 5 
5. Discussion 
This dissertation is comprised of three manuscripts that provide distinct contributions 
to the scientific knowledge of exposure assessment.  In the first manuscript (Chapter 2), I 
discuss my work to address the hypothesis that NKAs are formed on human epidermis upon 
the exposure to naphthalene-containing jet fuel (JP-8), and the strategies and results of 
developing the specific antibodies and ELISAs for detecting these adducts.  The second 
manuscript (Chapter 3) presents the research conducted with in vitro 3D reconstructed human 
skin exposed to naphthalene to investigate induction of xenobiotic-metabolizing enzymes and 
NKA formation.  It also presents the data regarding naphthyl-keratin adduct formation in vivo 
using tape-stripped samples collected from fuel-cell maintenance workers who were 
routinely exposed to naphthalene-containing JP-8.  The third manuscript (Chapter 4) presents 
the linear regression models to investigate external factors, such as dermal and inhalation 
exposure, work scenarios, etc. and personal factors, such as a priori selected genotypes of 
metabolic enzymes, that contribute to the levels of NKAs in the skin of the exposed workers.  
In addition, I investigated the relationship between NKAs and other JP-8 biomarker, and 
examined the use of the NKAs as biomarkers of dermal naphthalene/JP-8 exposure. 
5.1. Keratin Adducts as Biomarkers of Human Dermal Exposure to Aromatic 
Hydrocarbons 
PAHs, such as naphthalene, are ubiquitous and persistent environmental pollutants 
with significant potential for human dermal exposure and toxicity, including cancer.  
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However, there has been little investigation on dermal absorption, distribution, metabolism to 
reactive intermediates, and the mechanisms of action of observed toxicity.  The only method 
for quantitation of dermal dose of aromatic hydrocarbons reported to date (Chao et al., 2005) 
detects the unchanged parent compound (naphthalene) on the surface of the skin, which can 
be attributed to recent exposure (i.e., within hours) only.  Adducts of reactive metabolites of 
aromatic hydrocarbons that bound to keratin could potentially be utilized as appropriate 
biomarkers for chronic dermal exposure, as the bioactivation of naphthalene is required to 
generate these adducts occurs only in the suprabasal level of the epidermis where keratin is 
synthesized de novo (Watt, 1988a; Watt, 1988b).  Approximately 28 days are required for 
differentiation and maturation of suprabasal keratinocytes (Junqueira and Carneiro, 2005; 
Furukawa et al., 2008) to migrate from the basal layer to form the stratum corneum.  Thus, 
periodic non-invasive sampling by tape stripping could be used to determine prior and 
cumulative chronic dermal exposure and, potentially, provide some measure of variation in 
individual metabolic capacity. 
I developed methods to purify specific antibodies and ELISA to quantitate NKAs 
formed on the stratum corneum upon dermal exposure to naphthalene (Chapter 2).  This is 
the first report of naphthalene adducts or any PAH adducts formed in the skin of exposed 
humans in vivo.  This study confirms that our approach of chemical synthesis of epitope-
specific antigens combined with sensitive and specific ELISA should be adaptable for use 
with other low- and high-molecular weight aryl hydrocarbons or other electrophilic species, 
whether direct-acting or formed as a result of bioactivation.  Research has shown that 
intermediate filament is comprised of 1:1 ratio of K1 and K10; therefore, the significant 
differences in adduct levels between K1 and K10 was unexpected (Albers and Fuchs, 1992).  
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However, this phenomenon may be explained by various factors, such as altered K1 and K10 
expression levels due to exposure (Witzmann et al., 2005), or the differential accessibility or 
availability of the adduction sites on various cysteines on these proteins.  In order to 
effectively utilize the keratin adducts as biomarkers to accurately assess occupational and 
environmental dermal exposure, more research is needed to understand the exact 
mechanism(s) of keratin adduct formation, and the biological and physiological factors that 
may influence keratin adduct formation.  Quantitation of keratin adducts obtained from the 
stratum corneum of exposed individuals can facilitate the investigation of dermal penetration, 
metabolism, and adduction to keratin as well as to make accurate prediction of the 
contribution of dermal exposure to the systemic dose for inclusion in exposure- and risk-
assessment models. 
5.2. Exposure to Naphthalene Induces Naphthyl-Keratin Adduct Formation in Human 
Epidermis in Vitro and in Vivo 
Existence of several cytochrome P450 isoforms in the skin and their roles in 
metabolizing xenobiotics, such as naphthalene and other PAHs, have been observed in a 
number of studies (Gabbani et al., 1999; Piipari et al., 2000; Godschalk et al., 2001; 
Janmohamed et al., 2001; Lee et al., 2001; Nan et al., 2001; Saeki et al., 2002; Yengi et al., 
2003; Du et al., 2004; Kim et al., 2004; Shimada, 2006).  I exposed in vitro 3D full-thickness 
reconstructed human epidermis to naphthalene to demonstrate the existence and dose-related 
gene expression of various xenobiotic-metabolizing enzymes, including CYP2E1 (Chapter 
3).  I also demonstrated the dose-related naphthyl-keratin (2NK1) adduct formation in the 
epidermis using in situ immunofluorescence.  Further, I observed the presence of the NKAs 
in vivo in the skin of workers exposed to naphthalene-containing JP-8 (Chapter 3). 
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I observed significant differences in the TNKA levels between the five USAF bases, 
which were likely the result of the types of aircrafts and, particularly, the size of the fuel 
tanks, serviced in each base.  A significant difference was observed between the high- and 
medium-exposure groups (p = 0.069) but not between the high- and low-exposure groups (p 
= 0.916), which had the highest keratin adduct level.  The worker diaries revealed that 
majority of the a priori low-exposure workers actually participated in tasks such as repairing 
fuel lines, fuel tank draining and refueling, even though they did not participate in fuel-cell 
maintenance on the sampling day.  These results exemplified the inherent problem of 
exposure misclassification in epidemiology studies that rely on a priori determined job 
groups without the knowledge of quantitative exposure or biomarker of exposure data. 
Because of the nature of the NKAs as cumulative exposure biomarkers, additional 
research is required to understand the discrepancies between the NKA levels and the same-
day work and exposure scenarios, which are often used as surrogates for quantitative 
exposure measures in epidemiology studies.  In this study, only the highly exposed body 
regions identified by the subjects were sampled.  Therefore, the potential for under or over-
estimation of exposure may exist.  Little published information is also available regarding the 
adduction of xenobiotics to epidermal proteins after chemical exposure.  Future experiments 
with in vitro reconstructed tissue models can provide critical knowledge to the mechanistic 
processes required for protein adduction by xenobiotics.  In addition, repeated tape-strip 
sampling and measurements of keratin adduct levels during multiple work days, as well as 
increased number of sequentially collected tape-strips per sampling site and increased 
number of sampling sites monitored for exposure, will further facilitate the understanding of 
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the potential for keratin adduction and the utility of using keratin adducts as biomarkers of 
dermal exposure. 
5.3. The Utility of Naphthyl-Keratin Adducts as Biomarkers for Jet-Fuel Exposure 
Urine naphthalene and naphthols have been identified as biomarkers for systemic 
dosage for PAH exposure (Sobus et al., 2009b; Campo et al., 2010; Serdar et al., 2004).  In 
this study (Chapter 4), I further investigated the utility of the NKAs as biomarkers for dermal 
exposure to JP-8 by examining the relationship between the NKAs and urine naphthalene and 
naphthol metabolite levels in fuel-cell maintenance workers.  A significant correlation was 
only observed between the NKA and urine naphthalene levels.  I further observed that none 
of the four xenobiotic-metabolizing genes (GSTT1, GSTM1, CYP2E1, NQO1) were 
associated with the TNKA levels when personal and environmental factors were taken into 
account.  In contrast, when I investigated the urine naphthalene as the biomarker of systemic 
exposure, the presence of GSTT1 genotype (++/+-) and being carrier of the DD genotype of 
CYP2E1*6 gene were significant variables in the model along with the TNKA and the post-
exposure breath naphthalene levels and the worker’s gender. 
Although this study provides significant insight into the dermal exposure and 
formation of NKAs in the skin, this study had its limitations.  First, the lack of correlation 
between NKAs and urine biomarkers is of concern but may likely be due to the inherent 
differences in the biological life spans of these biomarkers as well as the various metabolic 
mechanisms and pathways involved in xenobiotic absorption, metabolism, detoxification, 
and excretion in different tissues and organs.  This lack of correlation has also been reported 
in several other studies (Jongeneelen et al., 1986; Jongeneelen and Bos, 1990; Sherson et al., 
1992; Omland et al., 1994; Ortega et al., 2003) and, thus, was not unexpected. More research 
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investigating the relationship between NKA and urine biomarker levels is urgently needed in 
order to understand the significance and implications for these observed differences.  Second, 
since the zygosity of the individual subjects genotype for the GSTM1-plus and GSTT1-plus 
genes could not be determined from the methods employed, the models may have over- or 
under-estimated the functional status and the significance and the contribution of the effects 
of these metabolic genes on the observed phenotypes.  A larger sample size for increased 
statistical power is needed in future studies in order to investigate genetic influences in the 
context of environmental/occupational exposure settings.  In summary, the TNKA level was 
affected by work scenarios and personal factors, and was associated with systemic dose 
biomarker, urine naphthalene, which render them good candidates as biomarkers for dermal 
exposure to JP-8. 
5.4. Overall Limitations and Future Research 
Because of the lack of information regarding the mechanism(s) of skin keratin adduct 
formation, there are possible unknown biological and physiological factors that may have 
influenced the observed NKA levels, which were not accounted for in my research.  More 
research is required to understand the keratin-protein adduction mechanisms and their 
relationship with physiological effects, such as inflammation responses that result in skin 
irritation.  Due to the long life span of the keratin adducts, multiple dermal samplings in 
combination with the chronicles of exposure/work scenarios and environmental 
measurements should be conducted in order to better study factors that may influence keratin 
adduct levels.  More research is also needed to investigate the relationships between various 
dermal and urine biomarkers to understand the contribution of dermal dose to the systemic 
dose.  In addition, research is needed to investigate the potential relationships between skin 
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keratin adducts and other protein adducts, such as albumin, hemoglobin, and DNA adducts, 
which are often used as biological effect biomarkers.  Lastly but not least, prospective 
epidemiologic studies utilizing keratin adducts as biomarkers are need in order to understand 
their significance and implications on biological and health effects of these workers. 
5.5. Scientific Contributions and Conclusions 
This is the first research study to demonstrate dose-related enzyme induction in 3D 
reconstructed human epidermis in vitro after exposure to naphthalene, and the first report of 
naphthalene-derived protein adducts formed in the human skin in vivo.  This is also the first 
study in which NKAs were utilized in exposure assessment investigating both environmental 
and genetic factors in regard to the relationships between skin adduct levels and urine 
biomarkers.  A significant association was found between the TNKA and urine naphthalene 
levels, a biomarker that has recently been identified for PAH exposure.  The results showed 
that the same approach can be used to investigate dermal exposure to other environmental 
contaminants, such as PAHs, in occupational or environmental settings.  These results also 
suggest that the TNKAs, as a measure of dermal exposure to naphthalene and/or 
naphthalene-containing jet fuel, show great promise as biomarkers of dermal exposure.  
Further studies are warranted in regard to the relationship between NKAs, biological effect 
markers, and potential health effects due to naphthalene and/or PAH exposure, to further 
explore the application of NKAs as biomarkers of exposure. 
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Appendix 
Appendix A: SAS Programs for Chapter 2 Statistical Analysis  
/*########################################################### 
Descriptive Statistics for Keratin and individual Adducts 
############################################################*/ 
Proc Means data=JP8.JP8_MasterTable_Final; 
 VAR TKeratin; 
Run; 
 
Proc Means data=JP8.JP8_MasterTable_Final; 
 VAR TK1_1NR_mole TK1_2NR_mole TK10_1NR_mole TK10_2NR_mole; 
Run; 
 
Proc Means data=JP8.JP8_MasterTable_Final; 
 VAR TK1AKR_mole TK10AKR_mole T1N_AKR_mole T2N_AKR_mole; 
Run; 
 
/*################################## 
T-Test Between Keratin Adducts 
######################################*/ 
/* 1NK1 vs. 2NK1 */ 
Proc Ttest data=JP8.JP8_MasterTable_Final; 
 Paired TK1_1NR_mole*TK1_2NR_mole; 
Run; 
/* p=0.0149*/ 
 
/* 1NK10 vs. 2NK10 */ 
Proc Ttest data=JP8.JP8_MasterTable_Final; 
 Paired TK10_1NR_mole*TK10_2NR_mole; 
Run; 
/* p<0.0001 */ 
 
/* Total 1-Naphthyl adduct vs. Total 2-Naphthyl adduct ratios */ 
Proc Ttest data=JP8.JP8_MasterTable_Final; 
 Paired T1N_AKR_mole*T2N_AKR_mole; 
Run; 
/* p<0.0001 */ 
 
/* Total Keratin 1 vs. Total Keratin 10 Adduct Ratio */ 
Proc Ttest data=JP8.JP8_MasterTable_Final; 
 Paired TK1AKR_mole*TK10AKR_mole; 
Run; 
/* p<0.0001 */ 
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Appendix B: SAS Programs for Chapter 3 Statistical Analysis  
 
/*############################## 
GEOMETRIC MEANS FOR TAKR_MOLE_LN 
By EXPOSURE LEVELS 
#################################*/ 
PROC GLM data=JP8.JP8_MasterTable_Final; 
 Class NewCat; 
 MODEL TAKR_mole_ln = NewCat; 
 LSMEANS NewCat/pdiff adjust=tukey; 
Run; 
 
/*####################################################################### 
PROC GLM CONTRAST for Significant differences in Total  
Keratin Adduct between Bases 
C-130E = Transport planes = BASE C, D 
F15 Fighter = BASE B, E 
A10 - BASE A 
#####################################################################/* 
Proc FREQ Data=JP8.JP8_MasterTable_Final; 
 Table BaseNum; 
Run; 
/* A=33, B=22, C=15, D=22, E=17 */ 
 
 
/* PROC GLM between All Bases */ 
PROC GLM data=JP8.JP8_MasterTable_Final Order=data; 
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans basenum/pdiff; 
Title2 "Significance using GLM Contrasts for Total keratin adduct between Transport 
and Fighter planes"; 
Run; 
/* Base A significantly different from all other bases p<0.0001 */ 
 
PROC GLM data=JP8.JP8_MasterTable_Final Order=data; 
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans basenum/pdiff cl adjust=tukey; 
Title2 "Significance using GLM Contrasts for Total keratin adduct between Transport 
and Fighter planes"; 
Run; 
 
/* Geometric means and STD for BASES - Table 1 */ 
PROC Means data=JP8.JP8_MasterTable_Final Order=data; 
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 Class BaseNum; 
 VAR TAKR_mole_ln; 
Run; 
/* Geometric mean and STD for all BASES - Table 1 */ 
PROC Means data=JP8.JP8_MasterTable_Final Order=data; 
 VAR TAKR_mole_ln; 
Run; 
 
 
/*########################################## 
/* PROC GLM contrast Transport (C, D) vs.  
Fighter (B, E) For TAKR_mole_ln  
############################################*/ 
PROC GLM data=JP8.JP8_MasterTable_Final Order=data; 
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum/solution; 
 Contrast 'Transport vs. Fighther' BaseNum  0 1 -1 -1 1; 
Title2 "Significance using GLM Contrasts for Total keratin adduct between Transport 
and Fighter planes"; 
Run; 
/* p<0.0001= significant differences between figheter and transport planes */ 
 
PROC GLM data=JP8.JP8_MasterTable_Final Order=data; 
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum/solution; 
 Contrast 'Base A vs. Fighter, B, E' BaseNum  -2 1 0 0 1; 
Title2 "Significance using GLM Contrasts for Total keratin adduct between Base A 
and Fighter planes"; 
Run; 
/*======================================= 
  Differences in TAKR_mole_ln levels between 
  Binary Variables (PPE, Demographic info) 
  in All Subjects   
=========================================*/ 
/* TESTING GENDER */ 
PRoc FREQ data=JP8.JP8_MasterTable_Final; 
 Table Gender; 
Run; 
PRoc means data=JP8.JP8_MasterTable_Final; 
 Class Gender; 
 VAR TAKR_mole_ln; 
Run; 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Class Gender; 
 Model TAKR_mole_ln = Gender; 
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 lsmeans Gender/pdiff adjust=tukey; 
Run; quit; 
 
%macro AllCAT (Var=,varname=); 
PRoc FREQ data=JP8.JP8_MasterTable_Final; 
 Table &Var; 
 Format Work_New work_Newfmt.; 
 Title2 "&VarName in All Categories";  
Run; 
PRoc means data=JP8.JP8_MasterTable_Final; 
 Class &Var; 
 VAR TAKR_mole_ln; 
Run; 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Class &Var; 
 Model TAKR_mole_ln = &Var; 
 lsmeans &Var/pdiff adjust=tukey; 
Run; quit; 
%Mend AllCAT ; 
 
/* Significant PPE and other Factors */ 
%AllCAT  (Var=Gloves,varname=Gloves);   /*p=0.0052*/ 
%AllCAT  (Var=Booties,varname=Booties);   /*p=0.0164*/ 
%AllCAT  (Var=Apron,varname=Apron);   /*p=0.0423*/ 
%AllCAT  (Var=Replacefoam, varname=Replacefoam); /*p=0.0057*/ 
%AllCAT  (Var=Ventilation,varname=Ventilation);  /*p=0.0014*/ 
 
/* Insignificant Factors */ 
%AllCAT  (Var=gender,varname=Gender);   /*p=0.8527*/ 
%AllCAT  (Var=Smoking,varname=Smoking);   /*p=0.2827*/ 
%AllCAT  (Var=Skinirritation,varname=Skin Irritation); /*p=0.3328*/ 
%AllCAT  (Var=Handlefoam,varname=Handlefoam); /*p=0.9766*/ 
%AllCAT  (Var=Removefoam,varname=Removefoam); /*p=0.1179*/ 
%AllCAT  (Var=Cottonoverall,varname=Cottonoverall); /*p=0.9151*/ 
%AllCAT  (Var=Respirator,varname=Respirator);  /*p=0.7078*/ 
/* Levels of TAKR_Exp between people with/without skin irritation */ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Class Skinirritation; 
 Model TAKR_mole_ln = Skinirritation; 
 lsmeans Skinirritation/pdiff adjust=tukey; 
Run; quit; 
 
Proc means data=JP8.JP8_MasterTable_Final; 
 Class Skinirritation; 
 VAR TAKR_EXP; 
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Run; quit; 
 
 
/* Levels of TAKR_Exp between Smokers/Non-smokers */ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Class Smoking; 
 Model TAKR_mole_ln = Smoking; 
 lsmeans Smoking/pdiff adjust=tukey; 
Run; quit; 
 
Proc means data=JP8.JP8_MasterTable_Final; 
 Class Smoking; 
 VAR TAKR_EXP; 
Run; quit; 
 
/*############################### 
BASES and Climates 
###############################*/ 
/* modify raw Data */ 
data JP8.Base_climate_Data; 
set JP8.Base_climate_Data1; /*"Modified Raw Data from "Base_Climate_Data"*/ 
  
  Rename Bases=Base; 
 
  Label  AvgHumiAM  = Average Humidity of the sampling month AM (%) 
  AvgHumiPM  = Average Humidity of the sampling month PM (%) 
  AvgPreci = Average Precipitation of the sampling month (in) 
  AvgTempH = Average Temperature of the sampling month High (oF) 
  AvgTempL = Average Temperature of the sampling month Low (oF) 
  Bases  = Air Force Base 
  GeoMeanAddRatio = Geometric mean of total adduct/keratin ratio 
[ln(pmole/ug)] 
  Sampling_Dates = sampling date or dates; 
   
Run; 
 
/* Run corrlation of the geometric mean Total Keratin1 adduct ratios(logged) from each base 
with AveTemp (H+L), AvePreci, Humidity */ 
proc corr data=JP8.Base_Climate_data pearson; 
 var GeoMeanAddRatio 
  AvgHumiAM 
  AvgHumiPM 
  AvgPreci 
  AvgTempH 
  AvgTempL;   
Run; 
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/*###################### 
Chater 2-TABLE 2 
########################*/ 
/* All Subjects*/ 
/* Keratin adduct Geometric means for each BASE */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Class BaseNum; 
 VAR TAKR_Exp; 
Run; 
 
/* Keratin adduct Geometric means for All BASES */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 VAR TAKR_Exp; 
Run; 
 
/* LSMeans T-test between bases */ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans BaseNum/pdiff Adjust=Tukey; 
 Title 'with Tukey adjustment'; 
Run; quit; 
/* significant differences between bases */ 
 
 
/*######################### 
/* High Exposure NewCat=1 
###########################*/ 
/* Keratin adduct Geometric means for high exposure 
NEWCAT =1 in each BASE */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=1; 
 Class BaseNum; 
 VAR TAKR_Exp; 
Run; 
 
/* Keratin adduct Geometric means for high exposure  
NewCAT=1 in All BASES */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=1; 
 VAR TAKR_Exp; 
Run; 
 
/* LSMeans T-test between bases */ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Where NewCat=1;  
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 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans BaseNum/pdiff Adjust=Tukey; 
 Title 'with Tukey adjustment'; 
Run; quit; 
/*######################### 
/* Medium Exposure NewCat=2 
###########################*/ 
/* Keratin adduct Geometric means for Medium exposure 
NEWCAT =2 in each BASE */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=2; 
 Class BaseNum; 
 VAR TAKR_Exp; 
Run; 
 
/* Keratin adduct Geometric means for Medium exposure NewCAT=2 in All BASES*/ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=2; 
 VAR TAKR_Exp; 
Run; 
 
/* LSMeans T-test between bases with Tukey adjustment*/ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Where NewCat=2;  
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans BaseNum/pdiff Adjust=Tukey; 
 Title 'with Tukey adjustment'; 
Run; quit; 
 
/*######################### 
/* Low Exposure NewCat=3 
###########################*/ 
/* Keratin adduct Geometric means for LOW exposure 
NEWCAT =3 in each BASE */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=3; 
 Class BaseNum; 
 VAR TAKR_Exp; 
Run; 
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/* Keratin adduct Geometric means for LOW exposure  
NewCAT=3 in All BASES */ 
PRoc Means data=JP8.JP8_MasterTable_Final; 
 Where NewCat=3; 
 VAR TAKR_Exp; 
Run; 
 
/* LSMeans T-test between bases with Tukey adjustment*/ 
Proc GLM data=JP8.JP8_MasterTable_Final; 
 Where NewCat=3;  
 Class BaseNum; 
 Model TAKR_mole_ln = BaseNum; 
 lsmeans BaseNum/pdiff Adjust=Tukey; 
 Title 'with Tukey adjustment'; 
Run; quit; 
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Appendix C. SAS Programs for Chapter 4 Statistical Analysis and Models   
/*################# 
Chapter 4 - Table 1 
####################*/ 
/* Pearson correlation between biomarkers */ 
Proc Corr data=JP8.JP8_MasterTable_1 pearson; 
VAR TAKR_mole_ln LNDermal LNPre LNPost LNPass LNUrineN1 LNUrineN2 
LNUrineNap LnNaphthol; 
Run; 
/*############################################### 
Chapter 4 - Table 3 
Total Keratin Adduct Model = All Subjects 
###############################################*/ 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model TAKR_mole_ln = LNDermal Exptime age/VIF COLLIN R; 
 Title "PROC REG on Total keratin adduct with possible predictors"; 
Run;Quit; 
/*Adj. R=0.2665, p<0.0001, N=103  */ 
 
/* Residual Plots */ 
symbol v=circle h=1 c=blue;  
PROC REG data=JP8.JP8_MasterTable_Final; 
 Title "Total keratin adduct model: All subjects"; 
 MODEL TAKR_mole_ln = LNDermal Exptime age; 
 PLOT Residual.*LNDermal; 
 PLOT Residual.*Exptime; 
 PLOT Residual.*age; 
 Plot Residual.*NQQ. / nostat nomodel noline; 
Run; 
 
/* HIGH Exposure only */ 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Where Newcat=1; 
 Model TAKR_mole_ln = LNDermal Exptime age/VIF COLLIN R; 
 Title 'PROC REG on Total keratin adduct with possible predictors'; 
Run;Quit; 
/*Adj. R=0.3513, p<0.0001, N=67, removefoam significant p=0.0676 */ 
 
/* Residual Plots */ 
symbol v=circle h=1 c=blue;  
PROC REG data=JP8.JP8_MasterTable_Final; 
 Where Newcat=1; 
 MODEL TAKR_mole_ln = LNDermal Exptime age; 
 Title "Total keratin adduct model: High Exposure"; 
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 PLOT Residual.*LNDermal; 
 PLOT Residual.*Exptime; 
 PLOT Residual.*age; 
 Plot Residual.*NQQ. / nostat nomodel noline; 
Run; 
/* Association between urine markers and Keratin adducts */ 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model LNUrineNap = TAKR_mole_ln; 
Run;Quit; 
 
Proc Reg data=JP8.JP8_MasterTable_1; 
 Model LNUrineratio_mole = TAKR_mole_ln; 
Run;Quit; 
 
Proc Corr data=JP8.JP8_MasterTable_1 Pearson; 
 VAR LNUrineratio_mole TAKR_mole_ln; 
Run;Quit; 
 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model LNUrineN1 = TAKR_mole_ln; 
Run;Quit; 
 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model LNUrineN2 = TAKR_mole_ln; 
Run;Quit; 
 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model LNNaphthol = TAKR_mole_ln; 
Run;Quit; 
 
Proc Reg data=JP8.JP8_MasterTable_Final; 
 Model LNUrineRatio_mole = TAKR_mole_ln; 
Run;Quit; 
 
/*############################################### 
Chapter 4 – Table 4 
Urine Naphthalene Model = All Subjects 
###############################################*/ 
Proc Reg data=JP8.JP8_MasterTable_1A; 
 Model LNUrineNap = TAKR_mole_ln GSTT1_type CYP2E1_type LNPost Gender 
 /VIF COLLIN R; 
 Title "urine Naphthalene MODEL 1C"; 
Run;Quit; 
/*Adj. R=0.3511, p<0.0001, N=96, TAKR_mole_ln, GSTT, CYP2E1 LNPost, Gender,  
VIF<10 CI-24.7*/ 
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/* Residual Plots */ 
symbol v=circle h=1 c=blue;  
PROC REG data=JP8.JP8_MasterTable_1A; 
Model LNUrineNap = TAKR_mole_ln GSTT1_type CYP2E1_type LNPost Gender;
 PLOT Residual.*TAKR_mole_ln; 
 PLOT Residual.*LNPost; 
 Plot Residual.*NQQ. / nostat nomodel noline; 
Run; 
/* HIGH Exposure only */ 
Proc Reg data=JP8.JP8_MasterTable_1A; 
 Where NewCat=1; 
 Model LNUrineNap = TAKR_mole_ln GSTT1_TYPE lnpost 
 /VIF COLLIN R; 
 Title "urine ratio MODEL 3A"; 
Run;Quit; 
/*Adj. R=0.2447, p=0.0002, N=64, TAKR_mole_ln, GSTT, LNPost VIF <10, CI=21.2*/ 
 
/* Residual Plots */ 
symbol v=circle h=1 c=blue;  
PROC REG data=JP8.JP8_MasterTable_1A; 
 Where NewCat=1; 
 Title "Urine Naphthalene Model 3A:High exposure Only"; 
 Model LNUrineNap = TAKR_mole_ln GSTT1_TYPE lnpost; 
 PLOT Residual.*TAKR_mole_ln; 
 PLOT Residual.*LNPost; 
 Plot Residual.*NQQ. / nostat nomodel noline; 
Run;Quit; 
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